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A B S T R A C T
Background
Shared decision making is an important component of patient-centred care. It is a set of communication and evidence-based practice
skills that elicits patients’ expectations, clarifies any misperceptions and discusses the best available evidence for benefits and harms
of treatment. Acute respiratory infections (ARIs) are one of the most common reasons for consulting in primary care and obtaining
prescriptions for antibiotics. However, antibiotics offer few benefits for ARIs, and their excessive use contributes to antibiotic resistance
- an evolving public health crisis. Greater explicit consideration of the benefit-harm trade-off within shared decision making may reduce
antibiotic prescribing for ARIs in primary care.
Objectives
To assess whether interventions that aim to facilitate shared decision making increase or reduce antibiotic prescribing for ARIs in
primary care.
Search methods
We searched CENTRAL (2014, Issue 11), MEDLINE (1946 to November week 3, 2014), EMBASE (2010 to December 2014) and
Web of Science (1985 to December 2014). We searched for other published, unpublished or ongoing trials by searching bibliographies
of published articles, personal communication with key trial authors and content experts, and by searching trial registries at theNational
Institutes of Health and the World Health Organization.
Selection criteria
Randomised controlled trials (RCTs) (individual level or cluster-randomised), which evaluated the effectiveness of interventions that
promote shared decision making (as the focus or a component of the intervention) about antibiotic prescribing for ARIs in primary
care.
Data collection and analysis
Two review authors independently extracted and collected data. Antibiotic prescribing was the primary outcome, and secondary
outcomes included clinically important adverse endpoints (e.g. re-consultations, hospital admissions, mortality) and process measures
(e.g. patient satisfaction). We assessed the risk of bias of all included trials and the quality of evidence. We contacted trial authors to
obtain missing information where available.
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Main results
We identified 10 published reports of nine original RCTs (one report was a long-term follow-up of the original trial) in over 1100
primary care doctors and around 492,000 patients.
The main risk of bias came from participants in most studies knowing whether they had received the intervention or not, and we
downgraded the rating of the quality of evidence because of this.
We meta-analysed data using a random-effects model on the primary and key secondary outcomes and formally assessed heterogeneity.
Remaining outcomes are presented narratively.
There is moderate quality evidence that interventions that aim to facilitate shared decision making reduce antibiotic use for ARIs in
primary care (immediately after or within six weeks of the consultation), compared with usual care, from 47% to 29%: risk ratio (RR)
0.61, 95% confidence interval (CI) 0.55 to 0.68. Reduction in antibiotic prescribing occurred without an increase in patient-initiated
re-consultations (RR 0.87, 95% CI 0.74 to 1.03, moderate quality evidence) or a decrease in patient satisfaction with the consultation
(OR 0.86, 95% CI 0.57 to 1.30, low quality evidence). There were insufficient data to assess the effects of the intervention on sustained
reduction in antibiotic prescribing, adverse clinical outcomes (such as hospital admission, incidence of pneumonia and mortality), or
measures of patient and caregiver involvement in shared decision making (such as satisfaction with the consultation; regret or conflict
with the decision made; or treatment compliance following the decision). No studies assessed antibiotic resistance in colonising or
infective organisms.
Authors’ conclusions
Interventions that aim to facilitate shared decision making reduce antibiotic prescribing in primary care in the short term. Effects on
longer-term rates of prescribing are uncertain and more evidence is needed to determine how any sustained reduction in antibiotic
prescribing affects hospital admission, pneumonia and death.
P L A I N L A N G U A G E S U M M A R Y
Interventions that facilitate shared decisions between primary care clinicians and patients about antibiotic use for acute respi-
ratory infections
Review question
Wewanted to see if shared decision making was better or worse than usual care in reducing antibiotic prescribing for an acute respiratory
infection in primary care.
Background
Shared decision making enables health decisions to be made jointly by a clinician and patient. The decision making occurs after the
options and their benefits and harms have been discussed together with the patient’s values and preferences.
Acute respiratory infections (such as an acute cough, middle ear infection or sore throat) are one of the most common reasons to see
a health professional, and antibiotics are commonly prescribed despite good evidence that they have little benefit for these conditions.
Any decision to prescribe an antibiotic should be balanced by any benefits against the risk of common harms (such as rash and stomach
upset) and the contribution to antibiotic resistance - now a major threat to human health.
Shared decision making provides an ideal opportunity within a primary care consultation for greater consideration about the trade-off
between benefit and harm of antibiotics for acute respiratory illnesses. Antibiotic prescribing may decrease as a result.
Study characteristics
We identified 10 studies (nine trials and one follow-up study) up to December 2014. In total, the studies involved over 1100 primary
care doctors and around 492,000 patients. The intervention was different in each study. Six of the studies involved training clinicians
(mostly primary care doctors) in communication skills that are needed to facilitate shared decision making. In three studies, as well
as training doctors in these skills, patients were also given written information about antibiotics for acute respiratory infections. All
included trials received funding from government sources. No studies declared a conflict of interest.
Key results
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Interventions that aim to facilitate shared decision making significantly reduce antibiotic prescribing for acute respiratory infections in
primary care, without a decrease in patients’ satisfaction with the consultation, or an increase in repeat consultations for the same illness.
There was not enough information to decide whether shared decision making affects other clinically adverse secondary outcomes,
measures of clinician and patient involvement in sharing decision making, or antibiotic resistance.
Quality of the evidence
We rated the quality of the evidence as moderate or low for all outcomes.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Shared decision making compared to usual care for acute respiratory infections in primary care
Patient or population: ant ibiot ic use in acute respiratory infect ions
Setting: primary care
Intervention: intervent ions to facilitate shared decision making
Comparison: usual care
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with usual care Risk with Interventions
to facilitate shared de-
cision making
Antibiot ics prescribed
or dispensed (6 weeks
or less)
assessed with: risk ra-
t io
Moderate RR 0.61
(0.55 to 0.68)
10172
(8 RCTs)
⊕⊕⊕©
MODERATE 1
47 per 100 29 per 100
(26 to 32)
Ant ibiot ics prescribed
or dispensed (12
months or greater)
assessed with: risk ra-
t io
Moderate RR 0.74
(0.49 to 1.11)
481588
(3 RCTs) 3
⊕⊕©©
LOW 12
47 per 100 35 per 100
(23 to 52)
Pat ient init iated re-con-
sultat ions for the same
illness episode
Moderate RR 0.87
(0.74 to 1.03)
1861
(4 RCTs)
⊕⊕⊕©
MODERATE 1
40 per 100 35 per 100
(30 to 41)
Pat ient sat isfact ion
with the consultat ion
Moderate OR 0.86
(0.57 to 1.30)
1052
(2 RCTs)
⊕⊕©©
LOW 14
71 per 100 68 per 100
(58 to 76)
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*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; OR: Odds rat io; RCT: randomised controlled trial; RR: Risk rat io
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded one level because of risk of bias: part icipants in most studies were aware of whether they had received the
intervent ion or not.
2 Downgraded one level because of imprecision: conf idence interval includes reduct ion and possible increase in use of
ant ibiot ics. There was considerable heterogeneity in the rates of ant ibiot ic prescribing during longer-term follow-up (12
months or greater).
3 Sample numbers in one trial, But ler 2012, were calculated f rom mean list size at baseline mult iplied by the number of
part icipat ing pract ices in each group (pract ice list sizes vary over t ime and no denominator data were available).
4 Downgraded one level due to imprecision: conf idence interval includes both sat isfact ion and lack of sat isfact ion of pat ients
with the consultat ion.
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B A C K G R O U N D
Description of the condition
Acute respiratory infections (ARIs) are one of the most common
reasons for consulting in primary care. Antibiotics are often pre-
scribed (Gill 2006; Gonzales 1997; Gonzales 2001), often unnec-
essarily as systematic reviews conclude that antibiotics have little
benefit for reducing symptom duration or complications in acute
otitis media (Venekamp 2015), sore throat (Spinks 2013), bron-
chitis (Smith 2014), and sinusitis (Ahovuo-Saloranta 2014), and
no benefit for laryngitis (Gonzales 2001) or colds (Kenealy 2013).
The limited benefits of antibiotics for ARIs may be outweighed
by unnecessary exposure to common adverse reactions (such as
diarrhoea, candidiasis, rash, abdominal pain and/or diarrhoea and
nausea and/or vomiting (Gillies 2015)), increased healthcare costs
and contribution to antibiotic resistance (Chung 2007; Costelloe
2010).
Several doctor- andpatient-related factors influence clinicians’ pre-
scribing behaviour. They include: clinical uncertainty and fear
of disease progression; inadequate physician knowledge (Altiner
2007); underestimates of the contribution of prescribing antibi-
otics to the development of resistance (Wood 2013); and perceived
patient expectations for an antibiotic and the subsequent pressure
felt to meet this expectation (Arroll 2002). Antibiotic prescribing
for ARIs also creates a ’vicious cycle’ through the medicalisation of
otherwise uncomplicated and self limiting illnesses, encouraging
patients to re-consult with similar expectations for an antibiotic
for similar illness episodes in the future (Butler 1998).
Antibiotic use exerts a selection pressure on bacteria to develop
resistance (WHO 2012). Patients prescribed an antibiotic for res-
piratory tract infections develop measurable bacterial resistance in
their commensal bacteria to that antibiotic for up to 12 months
(Costelloe 2010). Although the development of individual resis-
tance is transient, and decays after about a year in the absence
of antibiotic use, it is sufficient to sustain high levels of popu-
lation resistance (Chung 2007). Persistent prescribing of antibi-
otics, and excessive use of broad spectrum antibiotics in place of
narrower spectrum ones, are modifiable factors that contribute to
resistance (WHO 2012). Antibiotic resistance is now an evolving
global threat to public health (WHO 2012). The rational use of
antibiotics is therefore one of the most important strategies for
preserving the therapeutic benefit of antibiotic treatment (WHO
2001; WHO 2012).
Description of the intervention
Shared decision making is the process of enabling a health profes-
sional and patient to make a joint treatment or management de-
cision based on the best available evidence and the patient’s values
and preferences (Charles 1997; Makoul 2006). It consists of elic-
iting patients’ expectations and clarifying any misperceptions, dis-
cussing treatment options, and communicating the benefits and
harms of each option and their likelihood. Shared decision mak-
ing supports the principle of patient autonomy and the right to
self determination (Elwyn 2012), and has been shown to improve
patients’ satisfaction with decisions and concordance of decisions
with their values (Spatz 2012). Some of the skills required of clin-
icians to facilitate shared decision making include proficient com-
munication and rapport building skills as well as access to the best
available evidence. It is one of themost important ways of bringing
evidence to the point of clinical decisions and a potential strategy
for reducing the overuse of ineffective treatments (Elwyn 2012).
How the intervention might work
The diagnostic uncertainty associated with ARIs and the trade-off
between the benefits and harms of antibiotics mean that shared
decision making may provide an ideal opportunity for clinicians
and their patients to choose appropriate treatment ormanagement
options, including the decision to not use an antibiotic (Butler
2001). By engaging the patient and clinician to explicitly discuss
the benefits and harms of antibiotics against a background of ev-
idence demonstrating that it is less effective than most patients
expect, there is high potential for it to be effective. Many pa-
tients elect for conservative treatment options after participating
in shared decision making (Elwyn 2012).
Why it is important to do this review
Concern about antibiotic resistance is now an international public
health crisis (WHO 2012), and finding ways to minimise unnec-
essary antibiotic prescribing in primary care is imperative. Shared
decision making may be an important process to achieve this.
Several relatedCochrane systematic reviews have beenundertaken.
Arnold 2005 reviewed the effectiveness of interventions to im-
prove antibiotic stewardship in outpatient care (including the de-
cision to prescribe an antibiotic, and the type, dose and duration
of antibiotic therapy). However, broad inclusion criteria and sub-
sequent heterogeneity of the identified interventions limited the
generalisability of practice recommendations. Importantly, this re-
view also did not focus on, or explicitly consider, shared decision
making interventions for inclusion.
The review by Stacey assessed the effectiveness of decision aids for
people facing any treatment or screening decision (Stacey 2014).
Decision aids are only one tool used to facilitate shared decision
making in clinical care, and it may be enabled through methods
other than, or in addition to, decision aids. Similarly, the review
by Kinnersley evaluated the effect of interventions to encourage
patient health communication and information seeking prior to
the primary care consultation that shared some but not all compo-
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nents necessary for shared decision making to occur (Kinnersley
2007). Légaré 2014 assessed the effectiveness of interventions to
facilitate clinicians’ uptake of shared decision making but not the
use or effect of shared decision making in a particular condition.
The growing interest in shared decision making for potential im-
provement in treatment decisions and patient outcomes is evident
fromCochrane systematic reviews in other clinically important ar-
eas including mental health (Duncan 2010) and paediatric oncol-
ogy (Coyne 2013). If shared decision making is shown to reduce
prescribing among primary care doctors, then steps can be taken
to incorporate it into primary care consultations for ARI across
many countries.
O B J E C T I V E S
To assess whether interventions that aim to facilitate shared deci-
sion making increase or reduce antibiotic prescribing for ARIs in
primary care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) (individual level or cluster-
RCTs), which evaluated the effectiveness of shared decision mak-
ing in reducing antibiotic prescribing in primary care. Quasi-
RCTs, quasi-experimental studies (controlled clinical trials), con-
trolled before and after studies and interrupted time series analyses
were not eligible.
Types of participants
As interventions that aim to facilitate shared decision making may
be directed at clinicians, patients, or both, participants eligible for
this review could be:
1. clinicians who provide primary care (community practices,
hospital-affiliated or government-run outpatient clinics); or
2. patients who present with any combination of symptoms of
acute (less than four weeks’ duration) respiratory infection (or
the parents of similarly affected children).
Types of interventions
There is no one accepted definition of shared decision making
(Makoul 2006); nor is there consensus on the core skills that shared
decisionmaking training should address (Légaré 2013). Therefore,
we considered interventions eligible if the trial explicitly stated that
the intervention was aimed at facilitating shared decision making
or if the intervention explicitly addressed more than one of the
essential elements of shared decision making that are described
by Makoul 2006. These include: explaining the problem to be
addressed; discussing options; communicating benefits and risks
of each option; eliciting patient expectations, values, preferences
or concerns; discussing patients’ ability/self efficacy; and checking
or clarifying understanding.
These elements may have been addressed by providing training in
specific skills or providing decision support information or tools
(such as decision aids (Stacey 2014), option grids (Elwyn 2013), or
decision boxes (Giguere 2012)), which provide information about
relevant issues (such as options, benefits, harms, questions to ask,
etc). The skills training and information/tools could be provided
to either clinicians, patients, or both. Interventions may have been
delivered in any primary care environment and we imposed no
restriction on the training and/or information mode, format or
intensity of delivery.
We did not include interventions that consisted solely of the pas-
sive provision of patient information without the two-way shar-
ing of information necessary for shared decision making, or which
aimed to enhance clinicians’ and/or patients’ general communica-
tion skills.
Types of outcome measures
Primary outcomes
1. Prescription of antibiotics (for example, antibiotics
prescribed per consultation, or a change in the population rate of
antibiotic prescriptions per unit of time).
Secondary outcomes
1. Number or rate of patient-initiated re-consultations for
unresolved ARI (i.e. same illness episode).
2. Incidence of colonisation with, or infection due to,
antibiotic-resistant organisms.
3. Incidence of hospital admission.
4. Incidence of pneumonia (clinical with radiological
confirmation).
5. Incidence of acute otitis media complications (for example,
tympanic membrane perforation, contralateral otitis (in
unilateral cases), mastoiditis, meningitis).
6. Mortality due to respiratory illness or similar.
7. All-cause mortality.
8. Measures of patient and caregiver satisfaction.
9. Measures of patient and caregiver satisfaction with the
decision reached, decisional conflict and decisional regret.
10. Measures of extent of patient involvement in the decision
making process (for example, consultations analysed using tools
such as the OPTION instrument; Elwyn 2003).
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11. Measures of treatment compliance or adherence to decision
reached.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL 2014, Issue 11), which includes the Cochrane Acute
Respiratory Infections Group’s Specialised Register, MEDLINE
(1946 to November week 3, 2014), EMBASE (2010 toDecember
2014) and Web of Science (1985 to December 2014).
We searched MEDLINE using the search terms described in
Appendix 1. We combined the MEDLINE search with the
Cochrane Highly Sensitive Search Strategy for identifying ran-
domised trials in MEDLINE: sensitivity- and precision-maximis-
ing version (2008 revision); Ovid format.We used theMEDLINE
search strategy to search CENTRAL and adapted it to search EM-
BASE (Appendix 2) and Web of Science (Appendix 3). We im-
posed no language, publication date or publication status restric-
tions on the electronic database searches.
We searched the National Institutes of Health registry of clini-
cal trials (www.clinicaltrials.gov) and theWorld Health Organiza-
tion’s ( WHO) clinical trials registry ( www.who.int/ictrp/en/) for
completed and ongoing studies eligible for inclusion. We searched
Web of Science and EMBASE to identify potentially relevant con-
ference abstracts and proceedings.
Searching other resources
We searched the bibliographies of retrieved articles and pub-
lished reviews for additional studies.We personally communicated
with trial authors of significant publications and content experts
(Professor Paul Little, Professor Christopher Butler and Professor
France Légaré) to identify further published, unpublished or on-
going trials.
Data collection and analysis
Selection of studies
We merged search results into reference management software
(Endnote X6) and removed duplicate references. Two review au-
thors (PC, LM) independently screened the titles and abstracts
of retrieved records. We attempted to identify multiple reports of
single studies following the criteria recommended in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We retrieved full-text copies of all potentially relevant articles for
full-text evaluation. The final list of eligible trials was confirmed
following discussion and consensus among review authors (PC,
TH, LM, CDM).
Data extraction and management
Two review authors (PC, LM) independently extracted data from
each included trial using a specifically designed electronic data ex-
traction form. We resolved disagreements by discussion and con-
sensus, with one review author (CDM) acting as arbitrator where
required. Data extraction was blind to names of authors, institu-
tions and publication title. We extracted the following key study
features where available:
1. Trial characteristics and methodological quality - risk of
bias (see below); trial design, including unit of randomisation
and number of comparator arms; blinding; generation of
allocation sequence; allocation concealment; number of
participants; theoretical or conceptual basis of the intervention;
number of intervention components; description of intervention
and comparator arms; length of follow-up; sample size estimate
(power calculation); number of patients randomised to each
intervention arm; number of patients completing the trial;
reasons for withdrawal; and intention-to-treat (ITT) or per
protocol analysis.
2. Patient (and/or caregiver) characteristics - age, gender and
sociodemographic variables; types of ARI; duration of ARI prior
to study recruitment; co-morbidities.
3. Healthcare professional characteristics - age; gender;
experience; primary care setting type.
4. Outcome measures - all primary and secondary outcomes.
Assessment of risk of bias in included studies
Two authors (PC, LM) independently assessed the risk of bias of
included studies and two acted as arbitrators (TH, CDM). We as-
sessed risk of bias using the ’Risk of bias’ tool available in RevMan
2014 and the criteria explained in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We assessed
the reliability of the sequence generation, allocation concealment,
blinding (participants, personnel and outcome assessors), incom-
plete outcome data and selective outcome reporting bias, as well
as other sources of bias. We ranked studies as high, low or unclear
risk of bias as described in the Cochrane Handbook for Systematic
Reviews of Interventions and present our assessments in a ’Risk of
bias’ summary figure (Higgins 2011). As all included studies were
cluster-RCTs, we assessed additional sources of bias including re-
cruitment bias, baseline imbalance between clusters, loss of clus-
ters and incorrect analysis (Higgins 2011).
Measures of treatment effect
Measures of treatment effect included dichotomous (binary), rate
and continuous primary or secondary outcome data. Some studies
calculated mean difference (MD) for continuous outcomes (me-
dian difference or median and interquartile range where data are
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not normally distributed) and for dichotomous outcomes, risk ra-
tio (RR), odds ratio (OR) or rate ratio (RaR) were reported. In
accordance with our protocol we have based the primary analysis
on data reported as adjusted risk ratios. Additional analyses of the
prescribing outcomes also present adjusted odds ratios and risk
differences to incorporate additional information as analysed in
the included studies.
Unit of analysis issues
Studies presented effect measures adjusted for clustering effects
(at practice, provider and/or patient hierarchies) or potential con-
founders in multilevel analysis, and/or applied generalised lin-
ear mixed models or generalised estimating equations. Intraclass
correlation coefficients were estimated in sample size calculations
(Briel 2006; Cals 2009; Francis 2009; Légaré 2012; Little 2013;
Welschen 2004), or reported (Briel 2006; Francis 2009), to ac-
count for clustering effects. Where intraclass correlation coeffi-
cients were not reported (Butler 2012; Cals 2013), we imputed
them from another similar included study.
Dealing with missing data
The majority of studies performed ITT analyses (Briel 2006;
Butler 2012; Cals 2009; Francis 2009; Légaré 2011; Little 2013;
Welschen 2004). One study presented data only from practices
with complete follow-up (Altiner 2007). The long-term follow-
up study of Cals 2009 included data only where medical records
could be accessed for the follow-up period (87.9% of original trial
cohort) (Cals 2013). The principle of analysis was not stated in
one study (Légaré 2012). Drop-out rates and contributing reasons
were sufficiently disclosed in all studies, and one study reporting
relatively high attrition performed a sensitivity analysis to explore
effects from differential missing values (Altiner 2007).
Assessment of heterogeneity
We used a random-effects model for all meta-analyses due the ob-
served methodological diversity and used the I2 statistic to mea-
sure heterogeneity as recommended in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011).
Assessment of reporting biases
We minimised reporting bias by conducting a comprehensive
search for studies that met the eligibility criteria, including grey
literature and unpublished trials; and by contacting trials authors
for missing information. There were insufficient studies to test for
publication bias using a funnel plot.
Data synthesis
Meta-analyses of studies were limited to studies reporting a com-
parable effect estimate. Therefore, the test for overall effect is lim-
ited to analysis in each subgroup. Studies reporting data that could
not be combined for meta-analysis are reported narratively. Forest
plots were also not generated for data reported by a single study, or
where the synthesis of available pilot data to the substantive study
(for example, Légaré 2011) would not meaningfully increase the
power or precision of observed effects. Similarly, meta-analyses of
secondary outcomes were limited to studies reporting comparable
measures, those providing similar effect estimates, or where there
were sufficient trials for comparison (such as patient satisfaction
with the consultation). Caution is warranted for conclusions for
each outcome due to the low numbers of trials for each compar-
ison. We used RevMan 2014 to enter and analyse data to esti-
mate a weighted treatment effect (with 95% confidence intervals
(CIs). We analysed data using the random-effects model due to
the expected heterogeneity in combining diverse shared decision
making interventions.
We created Summary of findings for the main comparison us-
ing the following outcomes: antibiotic prescribing in the short
term (less than six weeks), longer-term antibiotic prescribing (12
months or longer), re-consultation for the same illness episode
and patient satisfaction with the consultation. We used the five
GRADE considerations (study limitations, consistency of effect,
imprecision, indirectness and publication bias) to assess the qual-
ity of evidence of the studies contributing data for meta-analyses
of prespecified outcomes (GRADE Working Group 2004). We
used the methods and recommendations described in Section 8.5
and Chapter 12 of the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011), using GRADEpro GDT software
(GRADEproGDT 2015). We justified decisions to downgrade or
upgrade the quality of studies using footnotes and comments to
aid the reader’s understanding of the review.
Subgroup analysis and investigation of heterogeneity
There were insufficient studies to conduct a subgroup analysis of
trials that incorporate shared decision making as part of a multi-
faceted intervention compared with trials in which shared deci-
sion making was the standalone intervention. Subgroup analysis
of interventions targeted at clinicians versus patients/parents was
also not conducted due to a lack of studies. We did not conduct
planned subgroup analyses of children versus adult trial popula-
tions, trials with low risk of bias versus high risk, and cluster-RCTs
versus individually randomised studies due to insufficient studies.
Sensitivity analysis
Insufficient studies prevented a planned sensitivity analysis exclud-
ing trials found to have a higher versus low risk of bias to examine
the effect of trial quality on the magnitude and direction of effect.
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R E S U L T S
Description of studies
Results of the search
We retrieved a total of 3272 studies from the searches of the elec-
tronic databases after duplicates were removed. Two review au-
thors (PC, LM) independently screened record titles and abstracts
and, following consensus, 3256 records did not meet our inclusion
criteria and were excluded. A recent published study protocol was
identified and we contacted the lead author to confirm the study
was ongoing and study results would not be available in time for
this review (Altiner 2012). We retrieved full-text reports of the
remaining 16 records and two review authors (PC, LM) screened
these independently. We excluded six studies after they did not
meet the a priori eligibility criteria for shared decision making in-
terventions. All review authors (PC, TH, LM, CDM) considered
the provisional list of 10 studies for inclusion. We contacted trial
authors of two of these studies for further elaboration on respec-
tive study interventions to determine that both were eligible for
inclusion (Altiner 2007; Briel 2006). We included 10 published
reports of nine original studies: one publication reports long-term
follow-up outcome data of an earlier study (Cals 2013), and an-
other published report, Légaré 2011, presents pilot data for rele-
vant outcomes distinct from the subsequent substantive cluster-
RCT (Légaré 2012). See Figure 1.
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Figure 1. PRISMA study flow diagram.
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Included studies
Study design
Six studies used a two-arm randomised group design: experimen-
tal versus control (usual care) (Altiner 2007; Butler 2012; Francis
2009; Légaré 2011; Légaré 2012; Welschen 2004). In one study
the control group received the intervention after the experimental
group had been exposed to the programme (Légaré 2011). Briel
2006 compared three arms: full intervention versus limited inter-
vention versus non-randomised controls that acted as distractors
to the intention of the real comparison and were not analysed).
Two studies compared four parallel study arms: intervention (a)
versus intervention (b) versus intervention (a + b) versus control
(Cals 2009; Little 2013). These two cluster-RCTs incorporated a
pre-specified factorial analysis plan (Cals 2009; Little 2013). Trial
data for interventions not relevant to the present review (such as
C-reactive protein point of care testing (Cals 2009; Little 2013),
or costs (Butler 2012)) are not presented.
All nine original studies included were cluster-RCTs. The unit
of randomisation in studies was the general practitioner (GP) (
Altiner 2007; Briel 2006), general practice (Butler 2012; Cals
2009; Francis 2009; Little 2013), GP peer review group (Welschen
2004), family practice teaching unit (Légaré 2012), and family
medicine group (Légaré 2011).
All trials received funding. None disclosed conflicts of interest
except Cals 2013 (one study author received travel/lecture funds
from a point of care test device manufacturer being evaluated in
the study, for which data were not relevant to this review). Ethical
approval was documented in all studies.
Characteristics of settings and participants
The studies were conducted in Germany (Altiner 2007), Switzer-
land (Briel 2006), the Netherlands (Cals 2009; Cals 2013;
Welschen 2004); England (Francis 2009), Wales (Butler 2012;
Francis 2009), and Canada (Légaré 2011; Légaré 2012). One
multinational trial was conducted across six European countries
(Netherlands, Belgium, Spain, Poland, England andWales) (Little
2013).
Recruitment of clinicians
Participating general practitioners (GPs) were recruited directly
(Altiner 2007; Briel 2006), or through participating general prac-
tices (Butler 2012; Cals 2009; Francis 2009; Little 2013), peer
review groups (Welschen 2004), family practice teaching units
(Légaré 2012), or family medicine groups (Légaré 2011). The
existing nationwide structure of GP peer review groups in the
Netherlands comprise GPs and collaborating pharmacists that
aim to promote rational prescribing through audit and feedback
(Welschen 2004). UK general practices comprise GPs and nurse
prescribers (Little 2013). GPs within Family Medicine Groups in
Canada (Quebec) also work closely with nurses for care of regis-
tered individuals (Légaré 2011). Family Practice Teaching Units
in Quebec include both physician teachers and residents (Légaré
2012).
Recruitment of patients
Specific ARI diagnoses and participant eligibility varied a little
across studies. In several studies GPs recruited all patients (adults
and children accompanied by a legal guardian) (Légaré 2011;
Légaré 2012;Welschen 2004), or only adult patients (Briel 2006),
consulting with symptoms of ARI. One study included adult pa-
tients presenting predominately with acute lower respiratory tract
infections (LRTIs) and upper respiratory tract infections (URTIs)
(Little 2013). Cals 2009 included adult patients only with sus-
pected LRTI. Altiner 2007 restricted patient eligibility to patients
over 16 years of age consulting for acute cough. Conversely, Butler
2012 included patients with any condition registered with partici-
pating practices. Francis 2009 included only children (six months
to 14 years) and their parents consulting for a respiratory tract
infection.
Study exclusion criteria also differed a little among studies.
Asthma was an explicit exclusion criterion in two studies (Altiner
2007; Francis 2009), and was not reason for exclusion in an-
other (Welschen 2004). Patients with chronic obstructive pul-
monary disease (COPD) were ineligible in one study (Altiner
2007), although were eligible for inclusion in two trials (Briel
2006; Welschen 2004). The proportion of patients diagnosed
with asthma/COPD ranged from ~ 2% to ~ 3.5% (Briel 2006;
Welschen 2004) up to ~ 18.5% (Little 2013). Patients with
pneumonia were excluded from participation in one study (Briel
2006). However, they were eligible in two studies (Little 2013;
Welschen 2004), and this was diagnosed in ~ 3.5% of participants
in Welschen 2004.
Characteristics of interventions and comparisons
Interventions
Included trials assessed various multi-component interventions
primarily aimed at facilitating clinicians shared management of
decisions to reduce antibiotics forARIs and their related symptoms
in primary care.
The delivery of interventions occurred in usual clinical settings or
central locations, and varied in intervention elements and scope
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and the frequency and duration (i.e. intensity) of sessions. All
studies provided education and communication skills training that
aimed to improve GPs’ understanding of topics such as: the prob-
ability of bacterial or viral ARI; evidence for the benefit/risk of
antibiotics and/or other treatment options; risk communication
techniques; information exchange about symptoms and natural
disease course; methods of eliciting patients’ concerns and expec-
tations; and agreement with the patient about a management plan
and summing up. Communicative techniques used were derived
from various theoretical models or frameworks.
Training in specific education and communication skills was de-
livered through peer- or facilitator-led interactive workshops and
seminars or viaweb-based platforms, and supportedwith the use of
videos, interactive exercises and decision aids or interactive book-
lets to facilitate patient participation in treatment decisions. Other
programme components in some studies included consensus pro-
cedures, simulated patient consultations, personal reflection on
clinical practice, reminders of expected behaviours and provision
of antibiotic resistance trend data. Several interventions contained
materials developed for patients, including education materials in
waiting rooms (poster and leaflet), an interactive booklet for use
within the consultation and as a take home resource, or decision
support tool).
A summary of the main intervention components is described
using the items from the Template for Intervention Description
and Replication (TIDieR) checklist (Hoffmann 2014) (see Table
1).
Comparators
In all trials the comparator was usual care, with the exception of
Briel 2006 where GPs received training in a two-hour seminar on
evidence-based US guidelines for ARIs.
Excluded studies
We excluded six studies as shared decision making was not ex-
plicit or inferred in the interventions evaluated (Characteristics of
excluded studies).
Risk of bias in included studies
The methodological characteristics of the studies are reported in
the Characteristics of included studies table. The ’Risk of bias’
summary and ’Risk of bias’ graph are presented in Figure 2 and
Figure 3, respectively.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Methods of sequence generation comprised computer and/or pro-
gram-generated methods (Altiner 2007; Briel 2006; Francis 2009;
Légaré 2011; Légaré 2012; Little 2013). Studies used stratification
and minimisation techniques (Little 2013), or dynamic block al-
location (Butler 2012; Francis 2009), to achieve balanced groups
on selected variables.
Concealed allocation occurred in most trials, with GPs blinded to
group allocation until after randomisation, although methods of
doing so were not clearly described in several trials (Altiner 2007;
Briel 2006; Cals 2009; Francis 2009; Little 2013;Welschen2004).
In Légaré 2012, the family practice units were recruited before
randomisation, but it is not clear when physicians in the units were
recruited/consented. In Légaré 2011, individual family physicians
were recruited after randomisation of the family medicine groups.
Blinding
The nature of the interventions meant blinding of the clinicians
delivering the intervention was not possible. Briel 2006 reported
blinding of general practitioners although this is not credible.
Blinding of outcome assessment was not reported in Little 2013,
although it was adequately described in all other included studies.
Incomplete outcome data
One study had high risk of attrition bias. Altiner 2007 reported
that 17% of GPs were lost to follow-up at six weeks post-interven-
tion and 41% at 12 months. The study authors explored the effect
of high attrition by conducting a cluster level sensitivity analysis by
imputing new values for missing average antibiotic rates: firstly, by
performing a regression analysis according to GPs with complete
data sets to receive a prediction rule of six weeks and 12 months
prescribing rates from baseline prescribing rates and, secondly, by
using these rules to estimate follow-up prescription rates for those
physicians that dropped out of the study. Alternative estimates
using last observations (baseline or six weeks) were similar, and
the results of both sensitivity analyses were in line with reported
results. Légaré 2012 reported that three of 12 randomised family
practice teaching units were lost to follow-up. The loss of clusters
was noted as a study limitation, but no further analysis was per-
formed. Neither of these studies reported conducting statistical
analysis on an intention-to-treat (ITT) basis.
The risk of attrition bias was low in the remaining studies.
Selective reporting
Several studies reported prospective trial registration (Butler 2012;
Cals 2009; Cals 2013; Francis 2009; Légaré 2012; Little 2013),
and/or had published trial protocols (Butler 2012; Cals 2009;
Francis 2009; Légaré 2011; Légaré 2012). We detected no report-
ing bias by comparing these to the final reports. Only Briel 2006
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neither reported trial registration nor published a protocol.
Other potential sources of bias
We considered recruitment bias to be minimal in the included
trials as the unit of allocation was recruited into the trial before
clusters were randomised. Similarly, we considered baseline imbal-
ances between study group characteristics minimal as all studies
disclosed baseline comparability and adjusted for important base-
line differences in the analysis. In two studies there was sufficient
loss of clusters following randomisation that may have introduced
bias (Altiner 2007; Légaré 2012). All studies sufficiently reported
the use of robust statistical methods to account for clustering in
the analysis.
All studies reported a sample size calculation with the exception of
Légaré 2011, which was designed as a pilot trial. An ITT analysis
was pre-specified in all but two trials (Altiner 2007; Légaré 2012).
Altiner 2007 included only practices with complete follow-up in
the analysis and themethod of analysis was not described in Légaré
2012.
The methods, timing and duration of patient recruitment varied
across studies. Recruitment in some trials was planned to capture
winter and/or autumn months (Cals 2009; Francis 2009; Légaré
2012; Welschen 2004). In the long-term follow-up study, Cals
2013, of the original cluster-RCT (Cals 2009), the end date of
the follow-up period was chosen to ensure a similar number of
winter days in each period. Recruitment in the Little 2013 study
occurred at the end of the season for respiratory tract infections
in participating European countries (February and May). One
trial included registered practice populations over an entire year
(Butler 2012). The timing and duration of participant recruitment
(e.g. during limited/winter months versus annual periods) may
influence study outcomes and seasonal variation in the frequency
and severity of ARIs may affect results.
The possibility of selection bias remains a possibility, although
trial authors report that the risk of bias was minimal as baseline
GP and patient characteristics were disclosed in all studies and
no systematic differences between known group characteristics or
case-mix were observed. Altiner 2007 could not rule out that GPs,
who were not monitored during the trial, may not have reported
patients with acute coughwho received an antibiotic. Participating
GPs in Briel 2006 were considered highly motivated and several
authors considered the possibility that GPs may have behaved
differently while being monitored (Hawthorn effect) (Briel 2006;
Francis 2009).
Intervention adherence was measured in only a few trials. Treat-
ment fidelity was not measured in any of the included studies and
sub-optimal exposure or delivery of the intervention as planned
may dilute the observed effect.
Effects of interventions
See: Summary of findings for the main comparison Shared
decision making compared to usual care for acute respiratory
infections in primary care
Primary outcome
1. Prescription of antibiotics
There were data from all 10 included studies on antibiotic pre-
scribing decisions for acute respiratory infection. However, they
could not all be combined into one meta-analysis because of dif-
ferences in adjusted effect estimates reported and outcome mea-
surement time.
We extracted event and denominator data, and reported (or im-
puted) intra-class correlation coefficients, to calculate the risk ratio
(RR) adjusted for the effects of clustering (Analysis 1.1; Analysis
1.2) to allowpresentation of outcome datawithin a common scale.
This also allowed us to combine trials reporting short (index con-
sultation to ≤ six weeks) and longer-term (≥ 12 months) inter-
vention effects on antibiotic prescribing. Eight studies reporting
short-termprescribing outcomes could be pooled inmeta-analysis:
the RR compared to usual care was 0.61, 95% confidence interval
(CI) 0.55 to 0.68; P value = < 0.001 (Figure 4). There was a trend
towards a reduction in antibiotic prescribing being maintained in
the longer term: RR compared with usual care 0.74, 95% CI 0.49
to 1.11; P value = 0.14 (Figure 5). However, the non-significant
results may be an artefact of the more conservative effect estimates
using RR adjusted only for clustering.
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Figure 4. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.1
Antibiotics prescribed, dispensed or decision to use (short-term, index consultation to ≤ 6 weeks).
Figure 5. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.2
Antibiotics prescribed or dispensed (longer-term, ≥ 12 months).
We also conducted a sensitivity analysis by pooling the results of
trials reporting similar adjusted effect estimates (see Analysis 1.3;
Analysis 1.4; Analysis 1.5). Three studies reported antibiotic pre-
scription as an odds ratio (OR) adjusted for clustering and other
covariates, and we were able to meta-analyse them: the pooled OR
compared with usual care was 0.44, 95% CI 0.26 to 0.75; P value
= 0.003 (Figure 6). Similarly a meta-analysis of two studies report-
ing a RR adjusted for clustering yielded a pooled RR compared
with usual care of 0.64, 95% CI 0.49 to 0.84; P value = 0.001
(Figure 7). A meta-analysis of four studies reporting an adjusted
risk difference (RD) yielded a pooled RD of -18.44%, 95% CI -
27.24 to -9.65% compared with usual care (Figure 8). The results
of the primary meta-analysis (RR adjusted for clustering) are gen-
erally concordant with trials reporting comparable adjusted effect
estimates, although not adjusting for covariates that may have dif-
fered slightly between randomised groups (which were adjusted
for in the reports) results in some loss of precision and wider 95%
CIs.
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Figure 6. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.3
Antibiotic prescriptions (index consultation) (adjusted odds ratio).
Figure 7. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.4
Antibiotic prescriptions (index consultation) (adjusted risk ratio).
Figure 8. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.5
Antibiotic prescriptions (index consultation or population rate per unit of time) (adjusted risk difference).
The absolute effect of the intervention for the outcome of antibi-
otics prescribed, dispensed, or decision to use, immediately after,
or within six weeks, of the consultation was reduced from 47% to
29%.
Francis 2009 showed important reductions in antibiotics pre-
scribed for children consulting for an ARI at the index consulta-
tion (intervention versus control: 19.5% versus 40.8%; adjusted
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OR 0.29; 95% CI 0.14 to 0.60. Francis 2009 was the only trial
that also reported data on antibiotics taken (this was collected by
telephone questionnaire). They reported the percentage of par-
ticipants in each group that took antibiotics within the first two
weeks (the data also include the antibiotics that were prescribed
after the index consultation: 50 (19.5%) in the intervention group
and 111 (40.8%) in the control group, with an adjusted OR of
0.35, 95% CI 0.18 to 0.66). A significant decrease in antibiotic
prescriptions for acute cough was observed in Altiner 2007 at six
weeks (adjusted OR 0.38, 95% CI 0.26 to 0.5; P value < 0.001)
and 12 months (adjusted OR 0.55, 95% CI 0.38 to 0.80; P value
= 0.002) post-intervention. Conversely, Briel 2006 was the only
trial that found no significant reduction in antibiotics dispensed
within two weeks of the index consultation (full intervention ver-
sus limited intervention: 13.5% and 15.7%; adjusted OR 0.86,
95% CI 0.40 to 1.93). DECISION+2 led to fewer patients decid-
ing to use antibiotics immediately after the consultation (imme-
diate versus no or delayed antibiotic use) for ARIs compared with
usual care (27.2% versus 52.2%; adjusted RR 0.5, 95% CI 0.3
to 0.7) (Légaré 2012). Little 2013 demonstrated that antibiotic
prescribing for predominately acute lower respiratory tract infec-
tions (LRTIs) and upper respiratory tract infections (URTIs) was
lower in the intervention group compared with controls (36.1%
versus 45.3%; adjusted RR 0.69, 95% CI 0.54 to 0.87). Cals
2009 demonstrated a reduction in antibiotic prescribing for pa-
tients with suspected LRTI recruited during the winters of succes-
sive years (2005 to 2006 and 2006 to 2007) (intervention versus
control: 27.4%, 95% CI 25.6% to 36.6% versus 53.5%; 95%
CI 43.8 to 63.2; P value < 0.01). Butler 2012 measured a mean
4.2% (95% CI 0.6% to 7.7%; P value = 0.02) reduction (as a
percentage of the mean in controls) in the total number of dis-
pensed oral antibiotic items per 1000 registered patients for the
year after the intervention practices were exposed to the STAR
programme. A non-significant reduction in the decision to im-
mediately use antibiotics was also observed in the pilot trial by
Légaré 2011 (-16.0%; P value = 0.08). Welschen 2004 reported
significantly reduced antibiotic prescribing rates for symptoms of
ARIs (-10.7%, 95% CI -20.3% to -1.0%). In a long-term follow-
up of Cals 2009, enhanced communication skills training showed
sustained reduction in antibiotic prescribing at 3.67 years mean
follow-up (intervention versus control: 26.3%, 95% CI 20.6% to
32.0 versus 39.1%, 95% CI 33.1% to 45.1%; corrected differ-
ence: -10.4%; P value = 0.02). See Table 2.
We graded the quality of evidence as moderate and low for antibi-
otic prescribing in the short term (less than six weeks) and long
term (12 months or longer), respectively. See Summary of findings
for the main comparison.
Secondary outcomes
1. Number or rate of patient-initiated re-consultations for
unresolved ARI
Six studies reported adjusted effect estimates that we could not
combine in a meta-analysis. We extracted data from four studies
to calculate a RR adjusted for clustering, and pooled in meta-
analysis. The RR compared to usual care was 0.87, 95% CI 0.74
to 1.03; P value = 0.11 (Analysis 1.6; Figure 9).
Figure 9. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.6
Number or rate of re-consultations (risk ratio).
The proportion of re-consultations for the same illness episode re-
ported in Briel 2006 was 44.7% versus 49.3% (adjusted RR com-
pared to controls 0.97, 95%CI 0.78 to 1.21). The between-group
consultation rates in Cals 2009 were 27.9% (95%CI 21.4 to 34.4)
and 37.0% (95% CI 30.4 to 43.6); P value = 0.14. Légaré 2012
reported no differences between groups (22.7% versus 15.2%; ab-
solute difference 7.5%; adjusted RR compared to controls 1.3,
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95% CI 0.7 to 2.3). Francis 2009 also reported no difference in
the odds of re-consulting in primary care during the two weeks
after the index consultation (12.9% versus 16.2%; adjusted OR
0.75 (0.41 to 1.38). Butler 2012 found no difference in median
re-consultation rates after an index consultation for respiratory
tract infections per 1000 registered patients at seven days (-0.65,
95% CI -1.69 to 0.55, P value = 0.446); 14 days (-1.33, -2.12 to
0.74; P value = 0.411); or 31 days (-2.32, 95% CI -4.76 to 1.95;
P value = 0.503). Similarly, Little 2013 found the rates of new or
worsening symptoms (including re-consultation in less than four
weeks or hospital admission) did not differ significantly between
groups (adjusted RR compared to controls 1.33, 95% CI 0.99 to
1.74; P value = 0.055). See Table 3.
We graded the quality of evidence as moderate. See Summary of
findings for the main comparison.
2. Incidence of colonisation with, or infection due to,
antibiotic-resistant organisms
No studies reported this outcome.
3. Incidence of hospital admission
Six trials reported serious adverse events (SAEs) requiring hospi-
talisation, although no significant differences between groups were
observed. Butler 2012 reported a non-significant difference in the
proportion of hospital admissions for possible respiratory tract in-
fections and complications relative to the control group (-1.9%,
95%CI -13.2% to 8.2%; P value = 0.72). Briel 2006 reported that
three patients were hospitalised (two patients in the full interven-
tion group versus one in the limited intervention group). Six inter-
vention and two usual care participants were hospitalised in Little
2013 (factorial analysis not reported). Francis 2009 reported seven
hospitalisations (intervention = three, control = four). There were
no occurrences of SAEs (death or admission to hospital) in Cals
2009. Cals 2013 reported five hospital admissions of 379 study
participants: two patients receiving usual care (four exacerbations
of chronic obstructive pulmonary disease (COPD) and one case
of pneumonia), one randomised to C-reactive protein testing, and
two episodes (pneumonia) in the combined intervention group
(factorial analysis data not reported). See Table 4.
4. Incidence of pneumonia
Two studies reported on the incidence of pneumonia. Briel 2006
reported one case of pneumonia in the control group, and Cals
2013 reported two cases of pneumonia in patients receiving a
combined intervention (factorial analysis data not reported) and
two cases of pneumonia in those receiving usual care. See Table 5.
5. Incidence of acute otitis media complications
No studies reported on this outcome.
6. Mortality due to respiratory illness or similar
One study, Briel 2006, reported a fatal myocardial infarction fol-
lowing pneumonia in an elderly patient receiving a limited (con-
trol) intervention.
7. All-cause mortality
No studies reported on this outcome.
8. Measures of patient and caregiver satisfaction
The results from two studies could be pooled, giving an OR com-
pared to controls of 0.86, 95% CI 0.57 to 1.30; P value = 0.47
(Analysis 1.7; Figure 10).
Figure 10. Forest plot of comparison: 1 Shared decision making versus usual care (control), outcome: 1.7
Patient satisfaction with the consultation.
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There were no differences observed between intervention and con-
trol groups in studies that reported this outcome. Briel 2006 found
no difference in scores for patient satisfaction (Patient Satisfaction
Questionnaire; score 0 to 70) between intervention and control
groups (median 68 out of 70; % patients with 70 out of 70: 47.8%
versus 49.0%; adjustedOR1.00; 95%CI 0.64 to 1.31). Cals 2009
reported no differences in patient satisfaction with the index con-
sultation (% at least very satisfied: 78.7%, 95% CI 72.5 to 84.9
versus 74.4%, 95% CI 68.2 to 80.6; P value = 0.88). In Francis
2009, the proportion of parents that were reported to be satisfied
or very satisfied with the consultation were similar between groups
(90.2% versus 93.5%; adjusted OR 0.64, 95% CI 0.33 to 1.22).
Patient satisfaction (one = very dissatisfied, five = very satisfied)
was also high and no between-group differences were observed in
Welschen 2004 (adjusted mean difference (MD) -0.03, 95% CI -
0.2 to 0.1). See Table 6.
We graded the quality of evidence as low. See Summary of findings
for the main comparison.
9. Measures of patient and caregiver satisfaction with the
decision reached, decisional conflict and decisional regret
Decisional conflict
One study measured GPs’ decisional conflict using the Decisional
Conflict Scale (DCS; 1 = low decisional conflict, 5 = very high
decisional conflict) and found no difference between the interven-
tion group and controls (MD 3.4, adjusted RR 3.5, 95% CI 0.3
to 38.0) (Légaré 2012). For patients’ decisional conflict scores, the
MD was 1.7 and the adjusted RR 0.8, 95% CI 0.2 to 2.4. See
Table 7.
Decision regret (patients)
Légaré 2012 observed a clinically insignificant effect between the
intervention and control groups on a decision regret measure (0
= very low regret, 100 = very high regret) with a mean of 12.4 in
the intervention group and 7.6 in the control group; adjustedMD
4.8, 95%CI 0.9 to 8.7. Légaré 2011 also reported no difference in
the proportion of patients with decisional regret between the study
groups (7% in the intervention group versus 9% in the control;
adjusted MD -2, 95% CI -12 to 5). See Table 8.
10. Measures of extent of patient involvement in the
decision making process
Patient enablement
Three studies reported on patient enablement. Cals 2009 found
no difference between intervention and control group scores on
the Patient Enablement Instrument (PEI; score 0 to 12) (mean
(SD): 3.29 (2.52) versus 3.06 (2.54); P value = 0.70). Francis 2009
found no between-group difference in a modified PEI measuring
parent enablement (score 0 to 10; score greater or equal five: 40.2%
versus 35.9%; adjusted OR 1.20, 95% CI 0.84 to 1.73). Briel
2006 found weak evidence for higher patient enablement on the
PEI (median 8 out of 12; mean (SD) 8.49 (1.98) versus 8.15
(2.03); adjusted MD 0.35, 95% CI -0.05 to 0.75). See Table 9.
11. Measures of treatment compliance or adherence to
decision reached
Decision quality
Légaré 2012 found no difference between GPs on a measure of
GPs’ decision quality (1 = very low quality, 10 = very high quality)
(MD -0.2, 95% CI -0.6 to 0.2). The results were similar to the
earlier pilot cluster-RCT, Légaré 2011 (MD -0.2, 95%CI -0.34 to
0.89; P value = 0.29). Similarly, there were no differences observed
in patients’ decision quality in Légaré 2012 (MD 0.0, 95% CI -
0.4 to 0.4) and Légaré 2011 (MD 0.1, 95% CI -0.88 to 0.94; P
value = 0.57). See Table 10 and Table 11.
Adherence to decision
The only trial to measure adherence to the decision reached found
no difference between intervention and control groups (87.7% of
patients versus 91.5%; absolute difference of 3.8, adjusted RR 1.0,
95% CI 0.9 to 1.0) (Légaré 2012).
D I S C U S S I O N
Summary of main results
Interventions aiming to promote shared decision making in pri-
mary care, as the focus or a core component of multi-faceted in-
terventions, significantly reduced antibiotic prescribing for acute
respiratory infections by almost 40% compared with usual care in
the short term. There was insufficient evidence for sustained re-
ductions in antibiotic prescribing over the longer term. There were
no significant differences between groups receiving the interven-
tion or usual care in clinical complications such as re-consultation
for the same illness, or patient satisfaction with the consultation.
There was also insufficient evidence to assess intervention effects
on other clinically adverse or patient and/or caregiver shared de-
cision process outcomes.
Overall completeness and applicability of
evidence
A growing number of trials have examined the effect of interven-
tions that aim to facilitate shared decision making, with all studies
being conducted in the last 10 years (seven of 10 studies in the last
five years), highlighting that shared decision making is a relatively
new intervention.
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All studies included acute upper or lower respiratory tract infec-
tion in children and/or adults consulting primary care or academic
general practice. Trials were conducted in several high-income Eu-
ropean countries and Canada. Applicability of findings to low-
and middle-income countries and different cultural and health-
care settings is unknown.
We identified considerable heterogeneity in longer-term prescrib-
ing outcomes meta-analysed as risk ratio (see Analysis 1.2), and
moderate to substantial heterogeneity in pooled results grouped
under each reported effect estimate for the primary outcome (see
Analysis 1.3; Analysis 1.4; Analysis 1.5). There was considerable
diversity across included studies within each comparison in terms
of the population (adults, children, or both), scale and composi-
tion of multi-component interventions evaluated, timing of the
intervention and follow-up, outcome measures used and statistical
techniques. The considerable heterogeneity observed in antibiotic
prescribing rates over the longer termmay be due to measurement
differences in one study (Butler 2012) (all oral dispensed antibiotic
items per 1000 registered patients for the year following exposure
of practices to the intervention), or the low number of studies re-
porting longer-term sustainability of intervention effects. Substan-
tial (although non-significant) heterogeneity apparent in studies
reporting an adjusted odds ratio (OR) (see Analysis 1.3; I2 statistic
= 57%; P value = 0.10)may have resulted from the inclusion of one
study reporting a statistically non-significant intervention effect
(Briel 2006), where an unusually low antibiotic prescribing rate
was noted (13.5% and 15.7% in the study groups) compared with
other studies. Detecting an intervention effect may be difficult in
a low prescribing setting. Some heterogeneity in pooled studies re-
porting an adjusted relative risk (Analysis 1.4; I2 statistic = 19%; P
value = 0.27) may result from true clinical and/or methodological
diversity with the non-significant result being simply an artefact
of only two studies being available for the comparison. Significant
heterogeneity in four studies reporting adjusted risk differences
(Analysis 1.5; I2 statistic = 37; P value = 0.19) is likely due to
inherent multiplicity of clinical and methodological factors.
The effect size of the included studies varied considerably, although
there was general consistency in the direction of effects. The risk
of bias overall in the included studies was low. Interventions var-
ied markedly in the theoretical basis, and the components, scope,
mode of delivery and duration. It is not possible, therefore, to iden-
tify which intervention components, combinations or modes of
delivery most effectively promote shared decisions. Interventions
and training were principally targeted at GPs. However, compe-
tence in the use of shared decision making was only reported in
some trials, with no studies assessing intervention fidelity. Objec-
tive patient or clinician measures of adoption of shared decision
making (e.g. OPTION (Elwyn 2003)) were not included in any
studies. The usefulness of interventions aimed primarily at pa-
tients to help facilitate their role in initiating and making shared
decisions remains unknown.
Quality of the evidence
We graded the quality of the evidence as moderate or low for all
outcomes. All cluster-level randomised controlled trials (RCTs)
used amethod of sequence generation aimed atminimising chance
between-group imbalance. All study participants (clusters) were
randomised after they were enrolled and prior to group allocation
to minimise selection bias. Blinding was not possible because of
the nature of the interventions. We considered only two studies
to have substantial loss to follow-up (Altiner 2007; Légaré 2012).
Altiner 2007 did not conduct an intention-to-treat (ITT) analysis
although they explored the effects of differential missing values in
cluster-level sensitivity analysis. An ITT analysis was not reported
by Légaré 2012.
Pooled studies for the primary outcome, antibiotic prescribing,
were limited by the diversity in adjusted effect estimates reported
and resulted in a low number of studies in each presented compar-
ison (see Analysis 1.3; Analysis 1.4; Analysis 1.5). This was sur-
mounted by calculating a risk ratio (RR) (using the design effect to
adjust for clustering) for meta-analysis (see Analysis 1.1; Analysis
1.2; Analysis 1.6), which results in some loss of precision, although
it is still robust (and more conservative at least). Similarly, meta-
analysis could not be performed for several clinically important
secondary outcomes due to variance in effect estimates reported
or measurement differences, which resulted in only a small num-
ber of trials being included for patient satisfaction (see Analysis
1.7). The low number of trials in addition to the presence of con-
siderable heterogeneity in the longer-term reduction in antibiotic
prescribing suggests that the overall pooled results and meaningful
exploration of heterogeneity was limited and should be interpreted
with caution. See Summary of findings for the main comparison.
Potential biases in the review process
Combining trials under a common effect estimate (RR) for antibi-
otic prescribing in the longer term (≥ 12 months) required us to
impute intra-class correlation coefficients for two studies (Butler
2012; Cals 2013), from similar studies, so that the design effect for
adjustment of clustering effects could be calculated. The results
for these outcomes should be interpreted with caution.
Agreements and disagreements with other
studies or reviews
Other systematic reviews have assessed clinician- and/or patient-
oriented interventions to influence antibiotic prescribing for acute
respiratory infections (ARIs) in primary care (Andrews 2012;
Arnold 2005; Boonacker 2010; Ranji 2008; Thoolen 2013; van
der Velden 2012; Vodicka 2013). Meaningful comparisons about
the relative effectiveness of studies is limited by the diversity in
study designs, interventions and outcome measures. Two reviews
concluded that multiple component interventions that provided
education to healthcare professionals and patients were most often
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effective in reducing antibiotic use for respiratory tract infections
(Arnold 2005; van der Velden 2012). Multi-faceted interventions
and computer strategies aimed at healthcare professionals most
effectively reduced antibiotic prescribing in children with upper
respiratory tract infections (Boonacker 2010). Provision of patient
information alone (Thoolen 2013), or in addition to physician
education (van der Velden 2012), appears to offer only moder-
ate or little additional benefit, respectively. However, reviews ex-
clude many recent high quality intervention trials incorporating
patient information materials and training explicitly aiming to fa-
cilitate shared decision making. Two reviews found that educa-
tional interventions directed at parents and/or caregivers were ef-
fective in modifying consulting behaviour and antibiotic use for
children with ARIs, and may be more successful when they engage
children (Andrews 2012; Vodicka 2013). Interventions were also
more successful when they were delivered prior to the consulta-
tion and focused on specific symptoms (Andrews 2012). Several
reviews concluded that a reduction in antibiotics was not at the
expense of adverse clinical outcomes (Ranji 2008), or patient sat-
isfaction (Andrews 2012; Ranji 2008; Thoolen 2013). Previous
reviews have raised the importance of a patient-centred approach
to help patients adopt a more active role in decision making about
antibiotics for ARIs (Thoolen 2013), and communication skills
training for physicians has been highlighted as a promising inter-
vention element (van der Velden 2012).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Interventions that aim to facilitate shared decision making reduce
antibiotic prescribing for acute respiratory infections (ARIs) in
primary care in the short term by a relative risk reduction of al-
most 40% compared with usual care, without an increase in pa-
tient-initiated re-consultations for the same illness or a decrease in
patient satisfaction. There is insufficient evidence that the effect
may be sustained in the medium to longer term (~ one to three
years). Whether the reduction in antibiotic prescribing achieved is
sufficient, or sustained long enough, to reverse community-level
resistance trends is not known as this was not measured in the in-
cluded studies. We graded the quality of the evidence as moderate
or low for all outcomes. The variety in the interventions and train-
ing components studied has important implications for knowing
which intervention components should be used in clinical prac-
tice, or how best to adapt successful programmes to other primary
care environments with different practice characteristics or access
to financial and core support resources.
Implications for research
The addition of future trials into this systematic review may al-
low greater precision of the effects of shared decision making and
an opportunity to explore reasons for the heterogeneity of the re-
sults. Evaluation of intervention adherence and fidelity (the de-
gree to which the intervention was delivered as intended) should
be incorporated into new studies. Further long-term follow-up
of included studies would also provide greater certainty regarding
the maintenance of intervention effects. Further research should
also aim to determine which aspects of these interventions pro-
vide the greatest benefit to adapt programme implementation and
uptake in diverse clinical settings. Research will also need to es-
tablish the link between a reduction in antibiotic prescribing for
ARIs in primary care and the reversal in community-level antibi-
otic-resistance trends, to validate the usefulness and sustainability
of programmes. Furthermore, while the interventions in studies
are principally aimed at developing general practitioners’ (GPs’)
communication skills to facilitate shared decision making, there
appears to be scope to pursue ways of involving healthcare con-
sumers in the design, planning and delivery of interventions to
promote shared decision making for ARIs in primary care. Finally,
although not relevant to the present review, the cost-effectiveness
of establishing shared decision making training programmes in
primary care to reduce antibiotic use for ARIs requires further re-
search interest.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Altiner 2007
Methods Study design: cluster-randomised controlled trial
Unit of randomisation: general practitioner (GP)
Trial duration: November 2003 to March 2005
Recruitment: 2036GPs from9 regions inNorth-Rhine andWestphalia-Lippe, Germany,
invited to participate (blinded to the primary outcome); of 239 GPs willing to participate
and receiving baseline materials, 104 completed reliable baseline study documentation
and were randomised (10 practice partners randomised as pairs) into intervention (GPs
= 52, patients = 1389) and control groups (GPs = 52, patients = 1398)
Methods of data collection: GPs recorded all consecutive and eligible patients during
each documentation period on study specific paper documentation
Data collection time points: 3 documentation intervals of 6 weeks each: baseline (before
randomisation), and 6 weeks and 12 months post-intervention
Length of follow-up: 12 months
Participants GPs documented all consecutive and eligible patients: ≥ 16 years of age with an initial
episode of acute cough (without prior episode < 8weeks) and could comprehendGerman
Exclusion: patients with underlying chronic lung diseases (e.g. asthma, chronic obstruc-
tive pulmonary disease), immune deficiency or malignant diseases
Interventions Brief intervention name: complex, peer-led, educational intervention
Recipients: GPs and patients (passive)
Providers: GP peers were trained to provide (in 3 sessions) the outreach visits in clinics
during normal working hours (methods of training these GP peers were not specified)
Health professional components: focused on antibiotic ’misunderstanding’ during a con-
sultation, and aimed to motivate GPs to change attitudes to communication and em-
power patients. Peers addressed GP beliefs and attitudes by exploring and evaluating
GPs ’opposite’ motivational background using a standardised dialogue script and com-
munication techniques derived from the elaboration likelihood model. Aspects of the
intervention were also informed by previous qualitative work
Patients: waiting room poster and leaflet focusing on the patients’ role within the antibi-
otic misunderstanding (e.g. GP perceptions that patients expect an antibiotic) and also
brief evidence-based information about acute cough and antibiotics to enable patients to
raise and clarify issues and make a joint decision about antibiotic use with their doctor
Materials: waiting room poster and leaflet (patient only); script used by GP peers
Mode of delivery: face-to-face (GPs) and waiting room posters and leaflets (patients)
Duration and intensity: 1 peer outreach visit per GP (duration not specified)
Comparator: nil active comparator; GPs provided usual care
Outcomes Primary: rate of antibiotic prescriptions per acute cough and by GP (study specific paper
documentation)
Secondary: nil
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: no
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Altiner 2007 (Continued)
Trial registration: yes
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Program-generated complete randomisa-
tion list
Allocation concealment (selection bias) Low risk Not described. However, GPs recruited
prior to randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (complex peer-led educational
intervention)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participating GPs sent data to researchers.
Each patient was assigned a unique iden-
tification number that could be connected
with the patient only by the participating
GP
Incomplete outcome data (attrition bias)
All outcomes
High risk Randomised: 104 GPs (intervention = 52,
1389 patients; control = 52, 1398 patients)
6 weeks post-intervention: 86 GPs (inter-
vention = 42 (80%), patients = 1021; con-
trol = 44 (84%), patients = 1143)
12 months post-intervention: 61 GPs (in-
tervention = 28 (54%); 787 patients; con-
trol = 33 (63%); 920 patients)
17% (18/104) dropped out at 6 weeks and
41% (43/104) by 12 months (reasons for
GPs’ exclusion from analysis: poor data
quality or did not return data)
Cluster-level sensitivity analysis performed
to explore effect of differential missing val-
ues
Selective reporting (reporting bias) Low risk All indicated results reported. Prospec-
tive trial registration: Projektdatenbank
Versorgungsforschung NRW, ID: 90/34/
CHANGE
Other bias Unclear risk Sample size (power) calculation: yes. Sam-
ple size calculated on number of patients
to detect a 10% difference in 6-month pre-
scription rates (50% control, 40% inter-
vention). Allowing for 20% drop-out rate,
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Altiner 2007 (Continued)
it was estimated 200GPswould be required
to contribute 20 patients during each ob-
servation period (i.e. 4000 at each of the 3
documentation periods)
ITT or per protocol analysis: no, all anal-
ysis (with exception of sensitivity analyses)
included only general practices with com-
plete follow-up
Large baseline difference found in antibi-
otic prescription rates between interven-
tion and control groups (36.4% versus 54.
7%) (unadjusted and adjusted analysis per-
formed)
GPs were not monitored during the trial
period and may have under-reported pa-
tients who received an antibiotic
Government regulatory change during
study to exclude OTC medicines from re-
imbursement by German statutory health
insurance funds may have increased antibi-
otic prescribing decisions to minimise pa-
tient out-of-pocket cost
Generalised estimating equation (GEE)
models applied
Intraclass correlation (coefficient): 0.20
Briel 2006
Methods Study design: cluster-randomised controlled trial
Unit of randomisation: general practitioner (GP)
Trial duration: January to May 2004
Recruitment: 345 eligible GPs (criteria undefined) from 2 Swiss cantons (Basel-Stadt
and Aargau), where self dispensation of drugs is not allowed. 30 GPs (providing written
consent by 1 December 2003) were randomised to limited or full intervention groups
(15 GPs each); the remaining 15 GPs (providing written consent by 1 January 2004)
formed the non-randomised control group
Methods of data collection: baseline data for eligible GPs obtained from the registry
of the Swiss Medical Association; GPs recorded patient baseline data; medical students
conducted standardised patient follow-up interviews at 7 and 14 days by telephone;
pharmacists faxed all prescriptions with study labels to the study centre
Length of follow-up: 14 days
Participants GPs recruited all consecutive and eligible adult patients: ≥ 18 years with symptoms of
acute infections of the respiratory system (first experienced within the previous 28 days;
including common cold, rhinosinusitis, pharyngitis, exudative tonsillitis, laryngitis, otitis
media, bronchitis, exacerbated COPD or influenza)
Exclusion: patients with pneumonia, not fluent in German, with intravenous drug use
or psychiatric disorders, and not available for phone interviews or unable to give written
informed consent
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Briel 2006 (Continued)
Interventions Brief intervention name: patient-centred communication training
Recipients: GPs
Providers: unclear
Health professional components: evidence-based guidelines (developed by 3 trial authors
based on existing US guidelines, adapted to local conditions and reviewed by local
experts) presented as a booklet and in a 2-hour interactive seminar, plus a 6-hour patient-
centred communication seminar in small groups (number not defined) and 2 hours of
personal feedback by phone prior to the start of the trial. Training aimed to teach GPs
how to understand and modify patients’ concepts and beliefs about the use of antibiotics
for ARIs. Physicians were taught to practice elements of active listening, to respond
to emotional clues and tailor information given to patients. GPs identified patients’
attitudes and readiness for behaviour change using a theoretical model (Prochaska and
DiClemente 1992)
Patient components: nil
Materials: evidence-based guidelines for the treatment of ARIs distributed as a booklet
(http://www.bice.ch/publications/reports)
Mode of delivery: booklet and face-to-face small-group interactive patient-centred com-
munication seminar
Duration and intensity: GPs attended 1 x 2-hour interactive evidence-based guidelines
seminar and 1 x 6-hour small group interactive patient-centred communication seminar
Comparator 1 (Limited intervention): evidence-based guidelines presented as a booklet
and in a 2-hour interactive seminar alone
Comparator 2 (Non-randomised control): usual care (data not extracted)
Outcomes Primary: antibiotic prescriptions dispensed by pharmacists < 2 weeks following initial
consultation (prescriptions with study labels faxed by pharmacists to the study centre)
Secondary: rates of different diagnoses of respiratory infections (GP records)
Adherence to guidelines for antibiotic prescription (GP records)
Days with restrictions from respiratory infection (patient follow-up interview at 7 and
14 days)
Days off work (patient follow-up interview at 7 and 14 days)
Re-consultation rates (patient follow-up interview at 7 and 14 days)
Patient satisfaction (Patient Satisfaction Questionnaire; patient follow-up interview at 7
and 14 days)
Patient enablement (Patient Enablement Instrument; patient follow-up interview at 7
and 14 days)
Other: serious adverse events (independent monitoring board review of serious adverse
events that occurred < 28 days of study enrolment)
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: no
Trial registration: not stated
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
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Briel 2006 (Continued)
Random sequence generation (selection
bias)
Low risk Computer-generated list created by an in-
dependent institution
Allocation concealment (selection bias) Low risk Allocation to either intervention was con-
cealed. However, method not stated.How-
ever, GPs recruited prior to randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of general practitioners and trial
staff reported. As this trial had 3 arms (2
intervention arms where the intervention
in each involved a seminar and distribution
of evidence guidelines; 1 usual care arm), it
is possible that the GPs in the intervention
arms would not have known which inter-
vention group they were in
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Medical students, blinded to the goal of the
trial, were trained to conduct standardised
follow-up interviews at 7 and 14 days by
phone
Prescriptions with study labels faxed by
pharmacists to the study centre were
checked and entered into the database by a
person blinded to the intervention group
Trial authors assessed adherence of all pre-
scriptions to guidelines independently and
blinded to the intervention group
Incomplete outcome data (attrition bias)
All outcomes
Low risk GPs randomised into limited intervention
(GPs = 15; patients = 293) and full in-
tervention groups (GPs = 15; patients =
259); 15 GPs (285 patients) participated
as non-randomised controls (data not ex-
tracted). All GPs completed the trial. There
were 290, 253 and a convenience sample
of 93 patients (stratified by physician), re-
spectively, interviewed at 7 days; and 287,
245 and 92 patients interviewed at 14 days.
Reasons for loss to follow-up reported
Selective reporting (reporting bias) Low risk All indicated results reported.Trial registra-
tion or published trial protocol not stated
Other bias Unclear risk Sample size (power) calculation: yes
ITT or per protocol analysis: ITT
Intraclass correlation (co-efficient) re-
ported: 4.0% and a design effect of 1.6%
Low study baseline prescribing rates - full
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Briel 2006 (Continued)
intervention (13.5%), limited intervention
(15.7%) and non-randomised control (21.
4%)
Highly motivated GPs: recruitment coin-
cided with introduction of a new nation-
wide computer-based reimbursement sys-
tem and due to increased workload partic-
ipating GPs considered to be highly moti-
vated
Butler 2012
Methods Study design: cluster-randomised controlled trial
Unit of randomisation: general practices
Trial duration: conducted during 2007 and 2008
Recruitment: 212 general practices approached at random from 454 eligible practices
in Wales, UK. 102 practices expressed interest to participate; 70 recruited; 68 practices
(~480,000 patients) randomised to intervention or control groups (34 each)
Methods of data collection: routine administrative systems (see ’Outcomes’)
Data collection time points: total numbers of dispensed oral antibiotic items (primary)
and hospital admissions for possible RTIs and their complications (secondary): rate per
1000 patients for the year after the intervention practices were exposed to the interven-
tion; re-consultation for RTIs: (secondary; 7, 14 and 31 days after initial consultation).
Cost data not extracted
Length of follow-up: 12 months
Participants Clinicians (general practitioners (GPs) and nurse practitioners) and all patients registered
with and consulting a participating general practice in Wales (practice list)
Interventions Brief interventionname: Stemming theTide of AntibioticResistance (STAR) educational
programme: multifaceted flexible blended learning approach to continuing education
for clinicians
Recipients: clinicians (GPs and nurse practitioners)
Providers: web-based modules and practice-based seminar led by a facilitator
Health professional components: the programme is a blended learning experience, and
based on Social Learning Theory to develop GPs sense of importance about change
(the ’why’ of change) and confidence in their ability to achieve change (the ’how’ of
change). The intervention consist of 7 parts (5 online, 1 face-to-face and 1 facilitator-led
practice-based seminar): case-scenarios and updated summaries of research evidence and
guidelines; reflections on clinical judgement on antibiotic prescribing; a facilitator-led
practice-based seminar presenting regional, local and practice-level antibiotic prescribing
and resistance data; novel communicative consulting skills and information exchange
based on motivational interviewing; personal reflections on clinical practice; web-based
forum to share experiences and views; and a booster module completed 6 to 8 months
after completion of the initial training to reinforce previously outlined communication
skills. GPs had to complete each online learning component before the software would
allow them access to the next. The intervention was flexible to allow GPs to access online
components and try out new skills with patients at their convenience
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Butler 2012 (Continued)
Patient components: nil
Materials: web-based materials
Mode of delivery: interactive web-based modules (including online videos in addition
to a facilitator-led practice-based seminar
Duration and intensity: not specified
Comparator: usual care
Outcomes Primary: total number of dispensed oral antibiotic items per 1000 registered patients for
the year after practices were exposed to the STAR programme (Prescribing Audit Reports
and Prescribing Catalogues; www.nhsbsa.nhs.uk/prescriptions)
Secondary: hospital admission rates for possible RTIs and their complications per 1000
registered patients for the year after practices were exposed to the STAR programme.
(Patient Episode Database for Wales); and practice re-consultation rates (for patients
with RTIs, practice re-consultation rates were identified using diagnostic READ codes
recorded by the general practitioner over 7, 14 and 31 days after an initial consultation)
Costs data not extracted
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: yes
Trial registration: yes
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was conducted once all
practices were recruited and all participat-
ing physicians had provided written con-
sent. Dynamic block allocation was used
to achieve balance between groups of prac-
tices for the potential confounders of previ-
ous rate of antibiotic dispensing (averaged
over the past year), practice size (number of
whole time equivalent staff at recruitment),
and proportion of clinicians in the practice
registered for the study. The practices were
divided into 3 sets of 24, 22 and 22 prac-
tices; within each set we generated all pos-
sible allocations into 2 groups and selected
the 1000 allocations within each set with
the best balance with respect to the speci-
fied confounders. The independent statisti-
cian on the trial steering committee selected
1 allocation at random for each set and ran-
domly assigned intervention or control to
the 2 groups in each set to construct the
final allocation
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Butler 2012 (Continued)
Allocation concealment (selection bias) Low risk Clinicians and researchers were blinded to
group allocation until after randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (multifaceted intervention
programme)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Data on antibiotic dispensing, hospital ad-
missions and re-consultations were col-
lected through routine administrative sys-
tems that were not influenced by the study
research process
Incomplete outcome data (attrition bias)
All outcomes
Low risk 68 practices (~480,000 patients) ran-
domised to intervention (34 practices; 137
GPs, 2 nurse practitioners) or control (34
practices; 122 GPS, 2 nurse practitioners)
groups. 2 practices (one in each group; in-
cluding 12 intervention GPs and 7 con-
trolGPs)withdrew after randomisationbut
were included in the ITT analyses
Selective reporting (reporting bias) Low risk All indicated results reported. Published
trial protocol available
Other bias Low risk Sample size (power) calculation: yes
ITT or per protocol analysis: ITT analysis
for primary outcome
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Cals 2009
Methods Study design: cluster-randomised controlled trial (factorial design)
Unit of randomisation: general practices (cluster of 2 general practitioners (GPs) per
practice)
Trial duration: conducted during the winters of 2005 to 2006 and 2006 to 2007
Recruitment: 54 general practices within a large suburban region of the Netherlands
were assessed for eligibility; 20 eligible general practices (with 2 participating GPs per
practice) were randomised into groups of 10 practices per intervention (resulting in 4
trial arms of 5 general practices and 10 GPs):
- use of C-reactive protein (CRP) testing;
- training in enhanced communication skills;
- use of CRP and training in enhanced communication skills;
- control (usual care)
Methods of data collection: antibiotic prescribing and re-consultation data obtained
from patient medical records. Patients rated symptoms (cough, phlegm, shortness of
breath, disturbance of daily activities, sleeping problems and generally feeling unwell)
, satisfaction and enablement, on a 28-day daily diary validated for use in a RCT on
management of LRTI in primary care
Data collection time points: index consultation and 28-day follow-up
Participants General practitioners recruited sequential eligible adults within regular consultation
hours during the winters of 2005 to 2006 and 2006 to 2007
Eligibility: suspected lower respiratory tract infection (LRTI) with a cough lasting < 4
weeks together with1 focal and 1 systemic symptom
Interventions Brief intervention name: enhanced communication skills training
Recipients: GPs
Providers: seminars led by a moderator
Health professional components: enhanced communication skills training involved 1 x
2-hour training seminar at a central location, preceded and followed by consulting with
simulated patients in routine surgeries and peer-review of transcripts. The moderator-
led seminar on shared decision making (within 1 week of simulated patient consultation)
comprised GPs’ reflection on simulated patient transcript, current views and insights on
LRTI (highlighting contrast between research and practice), outline of elicit-provide-
elicit framework (elicit patient’smainworries and expectations and conveying the balance
of possible antibiotic benefits and harms, provide information relevant to the patients’
individual understanding and interest, and elicit patients’ interpretation about what
has been said and done and discusses implications for help seeking behaviour), videos
presenting practice-based examples and GPs identifying specific aspects during their
consultations that need most attention
Patient components: nil
Materials: desk reminder for GPs
Mode of delivery: face-to-face seminar and simulated patient consultations with peer-
review of transcripts
Duration and intensity: 1 x 2-hour moderator-led training seminar; pre- and post-
seminar simulated patient consultations with peer-review of transcripts
Comparator 1: C-reactive protein point of care testing (date not extracted)
Comparator 2: enhanced communication skills training plus C-reactive protein point of
care testing (date not extracted)
Comparator 4: usual care (Dutch guidelines for managing acute cough, including diag-
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Cals 2009 (Continued)
nostic and therapeutic advice for lower respiratory tract infection are distributed to all
GPs in the Netherlands)
Outcomes Primary: antibiotic prescribing in the index consultation (medical records)
Secondary: antibiotic prescribing during 28 days’ follow-up (medical records)
Re-consultation (medical records)
Clinical recovery data not extracted
Patients’ satisfaction (Likert scale; 28-day daily diary)
Patients’ enablement (Patient Enablement Index; 28-day daily diary)
Notes Funding: yes
Conflict of interest: none declared
Published trial protocol: yes
Trial registration: yes
Ethics approval: yes
Main comparator reported in this review: communication skills training (n = 201) versus
no communication skills training (n = 230)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk General practices randomised into 2 groups
of 10 practices per intervention, balanced
for recruitment potential, resulting in the
4 trial arms. The balancing factor used
for randomisation was the amount of GP’s
consultation time (expressed as full time
equivalent (FTE)) that the practice was
contributing to the study (which equated
to between1 and 2 FTEs for clinical con-
tact time. The randomisation was balanced
for those with 1.5 or less FTEs and those
with more than 1.5 FTEs
Allocation concealment (selection bias) Low risk All practices and general practitioners were
recruited before randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (due to the nature of the in-
tervention)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk 20 practices (40 GPs) randomised to each
of the 4 trial arms (5 practices, 10GPs each)
and recruited 431 patients. 37 GPs com-
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Cals 2009 (Continued)
pleted the trial (3 left on maternity leave in
the enhanced communication skills group)
. All patients (100%) had data for the pri-
mary outcome, 90% (mean) had 28-day
diary data
For the communication skills training
group (10 GPs, 84 patients), there was
100% prescribing data and 88% returned
diaries
Selective reporting (reporting bias) Low risk All indicative results reported. Published
study protocol. Prospective trial registra-
tion
Other bias Low risk Sample size (power) calculation: yes
ITT or per protocol analysis: the primary
analysis was ITT
Cals 2013
Methods Study design: 3.5 year follow-up of a cluster-randomised controlled trial (factorial design)
(Cals 2009)
Trial duration: 3.5 years (mean 3.67 years)
Recruitment: patients recruited in the winter periods from September 2005 until March
2007 (Cals 2009), were observed until July 2010
Methods of data collection: medical records
Data collection time points: recorded consultations for RTI from original 28-day follow-
up period until July 2010 (follow-up period); recorded consultation for RTI for the exact
same period preceding the consultation in which the patient was recruited in the original
trial (baseline period). Deceased patients and patients that moved practices and whose
medical records could not be retrieved were excluded
Length of follow-up: mean 3.67 years
Participants General practices: see Cals 2009
Patients: of the original 431 patients enrolled in the trial, 379 patients (87.9%) had ac-
cessible medical records for the follow-up period. Only data for the enhanced communi-
cation training (178) versus no enhanced communication skills training (201) extracted
Interventions See Cals 2009
Outcomes Primary outcome: average number of episodes of RTIs during the follow-up period for
which patients consulted their physician per patient per year (PPPY) and the proportion
of these episodes that resulted in an antibiotic prescription
Secondary outcome: nil
Notes Funding: yes
Conflict of interest: RH received travel/lecture funds from Axis-shield (Norway) and
Orion Diagnostica (Finland), both manufacturers of C-reactive protein devices
Trial registration: yes
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Cals 2013 (Continued)
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk See Cals 2009
Allocation concealment (selection bias) Low risk See Cals 2009
Blinding of participants and personnel
(performance bias)
All outcomes
High risk See Cals 2009
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Data were extracted, by 2 researchers, from
the patients’ medical records system. No
mention if these researchers were blind to
the practices’ original allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 379 of 431 patients enrolled in the orig-
inal trial (87.9%) had accessible medical
records for the follow-up period
Selective reporting (reporting bias) Low risk See Cals 2009
Other bias Low risk Sample size (power) calculation: see Cals
2009
ITT or per protocol analysis: see Cals 2009
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Francis 2009
Methods Study design: cluster-randomised controlled trial
Unit of randomisation: general practices
Trial duration: October 2006 to April 2008
Recruitment: half of all general practices from 9 local health boards in Wales (n = 147)
were randomly selected to be sent study information (the other half were provided infor-
mation about a related RCT conducted in parallel); 49 returned a practice agreement and
were randomised. 4 primary care research networks in England also recruited practices;
34 returned practice agreement and were randomised. All randomised practise (83) were
allocated to intervention (41 practices; 30 recruited patients; patients = 274) or control
(42 practices; 31 recruited patients; patients = 284)
Methods of data collection: baseline data (age, duration of illness, symptoms) collected
by GPs. Follow-up via a telephone administered questionnaire (or self completion ques-
tionnaire contact unsuccessful by telephone) with child’s parent or guardian
Data collection time points: index consultation and 14 days after recruitment
Length of follow-up: 14 days
Participants Participating clinicians recruited sequential eligible children (6 months to 14 years)
consulting with a respiratory tract infection (cough, cold, sore throat, earache for 7 days
or less) and their parents
Exclusion: children with asthma and those with serious ongoing medical conditions such
as malignancy or cystic fibrosis
Interventions Brief intervention name: interactive booklet on respiratory tract infections in children
for use within the consultation and provided as a take home resource
Recipients: parents and clinicians
Providers: not stated
Health professional components: the online training described the content and aims of
the booklet, and encouraged its use within the consultation to facilitate the use of certain
communication skills, mainly exploring the parent’s main concerns, asking about their
expectations, and discussing prognosis, treatment options and any reasons that should
prompt re-consultation
Patient components: use of the booklet in the consultation and as a take home resource
Materials: 8-page interactive booklet (see www.whenshouldiworry.com)
Mode of delivery: 8-page interactive booklet and online training for clinicians in use of
the booklet
Duration and intensity: not stated
Comparator: usual care (clinicians were asked to conduct consultations in usual manner)
Outcomes Primary: re-consultation (primary or secondary care) during the 2 weeks after the index
consultation (telephone administered questionnaire)
Secondary: antibiotic prescriptions (telephone administered questionnaire)
Antibiotic consumption (telephone administered questionnaire)
Future consulting intention (telephone administered questionnaire)
Parental satisfaction with the index consultation (5-point Likert; telephone administered
questionnaire)
Parental enablement (modified Patient Enablement Instrument; telephone administered
questionnaire)
Perception of the usefulness (value) of the information received during the index con-
sultation (5-point Likert; telephone administered questionnaire)
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Francis 2009 (Continued)
Parental reassurance (3-point Likert; telephone administered questionnaire)
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: yes
Trial registration: yes
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Practices were randomised by a statistician
using block randomisation with random
block sizes and stratification by practice list
size, antibiotic prescribing rate for 2005,
and country
Allocation concealment (selection bias) Unclear risk It is reported that practices were ran-
domised after agreeing to take part, but no
other details are provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (training and use of an inter-
active booklet for use within consultations
and as a take home resource)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Telephone interviewers were blinded to
treatment group and asked to record any
subsequent unblinding of allocation (e.g.
parent talking about receiving a booklet)
. Interviewers reported becoming aware of
participants treatment group in 34/509 (6.
7%) of interviews
Incomplete outcome data (attrition bias)
All outcomes
Low risk 83 practices were randomised to inter-
vention (41) or control (42) groups; 61
practices, 30 intervention and 31 control
practices, recruited 274 and 284 patients,
respectively. Primary outcome data were
available for 256 patients (93%) in the
intervention group (246 completed tele-
phone interviews, 10 postal questionnaire
returned) and 272 (96%) control group
patients (262 completing telephone inter-
views, 9 postal questionnaires returned)
Selective reporting (reporting bias) Low risk All indicted outcomes reported. Published
trial protocol
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Other bias Low risk Sample size (power) calculation: yes
ITT or per protocol analysis: primary anal-
ysis was ITT
Little 2013
Methods Study design: cluster-randomised controlled trial (factorial design)
Unit of randomisation: general practices
Trial duration: October 2010 to May 2011
Recruitment: all general practices (n = 440) in the localities of study centres were ap-
proached, and all clinicians (and nurse prescribers in the UK) in eligible practices who
prescribed antibiotics for respiratory tract infections were invited to participate Eligibil-
ity: practices that had not previously used interventions to reduce antibiotic prescrib-
ing and could include > 10 patients at baseline audit. Networks of at least 2 practices
were selected separately in Antwerp (Belgium), Barcelona (Spain), Cardiff (Wales), ód
(Poland), Southampton (UK), Szczecin (Poland), Utrecht (Netherlands) and the Span-
ish Society of Family Medicine (Spain) to ensure a range of cultures, languages and re-
gions of Europe (north, south and east) were represented). Of the 259 eligible practices
enrolled; 246 were randomised to usual care (n = 61), training in the use of a C-reactive
protein (CRP) test at point of care (n = 62), training in enhanced communication skills
(n = 61), or in both CRP and enhanced communication skills training (n = 62)
Methods of data collection: case report forms (index consultation and follow-up)
Data collection time points: index consultation and follow-up (until resolution of symp-
toms)
Participants General practitioners (GPs and nurse prescribers in the UK) who prescribed antibiotics
for RTIs consecutively recruited up to the first 30 patients with LRTI and up to the
first 5 with URTI presenting at each practice. Eligible patients were ≥ 18 years of age,
attending a first consultation for acute cough of up to 28 days’ duration or what the
clinician believed to be an acute LRTI as themain diagnosis, despite cough not being the
most prominent symptom; and diagnosis judged by the physician to be an acute upper
respiratory tract infection (e.g. sore throat, otitis media, sinusitis, influenza and coryzal
illness)
Exclusion: patients with a working diagnosis of a non-infective disorder (e.g. pulmonary
embolus, heart failure, oesophageal reflux, or allergy); use of antibiotics in the previous
month; inability to provide informed consent (e.g. due to dementia, psychosis or severe
depression); pregnancy; and immunological deficiencies. Pneumonia was not an exclu-
sion criterion
Interventions Brief intervention name: enhanced communication skills training
Recipients: GPs
Providers: n/a
Health professional components: training focused on the gathering of information on pa-
tients’ concerns and expectations; exchange of information on symptoms, natural disease
course and treatments; agreement of a management plan, summing up and providing
guidance about when to re-consult. Physicians were provided with an interactive booklet
to use during consultations that included information on symptoms, use of antibiotics
and antibiotic resistance, self help measures, and when to re-consult. The training was
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supported by video demonstrations of consultation techniques. The Internet modules
and materials were translated into the relevant national language and mainly addressed
lower respiratory tract infections, although many of the issues were relevant to all respi-
ratory tract infections
Patient components: interactive booklet used within consultations
Materials: interactive booklet for use within consultations
Mode of delivery: Internet training supported by video demonstrations of consultation
techniques
Duration and intensity: not described
Comparator:
1. Usual care
2. Training in use of C-reactive protein (CRP) test at point of care (data not extracted
for this review)
3. Both CRP and enhanced communication skills training (data not extracted for this
review)
Outcomes Primary: antibiotic use (index consultation; case-report form)
Secondary: new or worsening symptoms defined as re-consultation for new or worsening
symptoms < 4 weeks, new signs or hospital admission (review of medical notes)
Symptom severity and duration defined as the severity of symptoms in the 2 to 4 days
after seeing the physician (case report form; 0 = no problem to 4 = severe problem)
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: no
Trial registration: yes
Ethics approval: yes
ITT or per protocol analysis: ITT analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation of practices was done by 2
study authors, and was achieved by com-
puter generationof randomnumbers, strat-
ified by network. Minimisation was ap-
plied, on the basis of the proportion of pa-
tients prescribed antibiotics from the base-
line audit, the number of participating
physicians per practice, and the number of
patients recruited
Allocation concealment (selection bias) Low risk Physicians and patients were unaware of
initial group allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (due to the nature of the in-
tervention)
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Blinding of outcome assessment (detection
bias)
All outcomes
High risk GPs recorded data on a case-report from,
during the index consultation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 259 practices enrolled and provided base-
line data (6771 patients); 13 practices re-
cruited < 10 patients each) were excluded
Remaining were 246 practices randomised
to CRP (62), enhanced communication
training (61), both interventions combined
(62), or usual care (61)
Antibiotic prescription documentationwas
available for 58 CRP practices (1062 pa-
tients), 55 (90%) enhanced communica-
tion skills practices (1170 patients), 62
combined intervention practices (1162 pa-
tients) and 53 (87%) usual care practices
(870 patients). Reasons for exclusion were
reported as recruiting no patients
Selective reporting (reporting bias) Low risk All indicated outcomes are reported
Other bias Low risk Sample size (power) calculation: not stated
ITT analysis: yes
Légaré 2011
Methods Study design: cluster-randomised controlled trial (pilot)
Unit of randomisation: family medicine groups (FMGs)
Trial duration: during November 2007 and March 2008
Recruitment: 24 FMGs (group of family physicians whowork closely with nurses to offer
family medicine services to registered individuals) from the greater urban area of Quebec
City, Canada, were invited to participate; 4 participating FMGs were randomised either
to a group immediately exposed to the DECISION+ program (n = 2) or to a control
group which exposure to DECISION+ program was delayed for 6 months (n = 2)
Methods of data collection: self administered questionnaire completed following the
consultation at each time point
Data collection time points: baseline, following exposure of the intervention group to
DECISION+ (~ 6months), and following delayed exposure of DECISION+ to controls
(~ 12 months)
Length of follow-up: 12 months
Participants Eligible general practitioners (no previous participation in an implementation trial of
SDMand planned to remain in clinical practice for the trial duration) recruited eligibility
patients consulting their GP for an ARI: no age restriction, patients or their guardians
had to be able to read, understand and write French and had to give informed consent
to participate in the trial
Exclusion: patients with a condition requiring emergency care. A research professional
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waited in the FMG’s waiting room and recruited patients of enrolled FPs during walk-
in clinic hours; 15 patients were recruited per GP: 5 at baseline, 5 after the GPs in the
experimental group were exposed to DECISION +, and 5 after the FPs in the control
group were exposed to DECISION+
Interventions Brief intervention name: DECISION+
Recipients: GPs
Providers: principal investigators (or co-trainers)
Health professional components: DECISION+ is made up of 3 main components
1. Interactive workshops addressed the probability of bacterial versus viral ARIs in pri-
mary care, evidence of the benefit/risk of the various treatment options, risk communica-
tion techniques and strategies for fostering patient participation in the decision making
process. Workshops included videos of simulated patient-GP consultations for each ARI
and distinguished 2 approaches (usual care or SDM), and exercises to facilitate group dis-
cussion about facilitators and barriers to SDM. GPs were trained to use decision support
tools (though video examples and group exercises) developed for each of the 4 targeted
ARIs (rhinosinusitis, pharyngitis, bronchitis and acute otitis media) and 1 integrating
all 4 ARIs
2. Reminders of expected behaviours: a reminder printed on a letter-sized piece of paper
emphasised the use of the decision support tools, reiterated the expected SDM-related
behaviours, and highlighted new studies relevant to the pilot trial topics (e.g. new ev-
idence on the risks and benefits of antibiotics). These reminders were mailed to GPs
between each workshop. A second reminder was postcards that participants had written
to themselves in the last workshop to remind themselves of what they needed to imple-
ment in their practice. The research team collected the postcards and mailed them 6 to
8 weeks later
3. Feedback to GPs on the agreement between their decisional conflict scores and that
of their first 5 patients
Patient components: decision support tools
Materials: a booklet summarising the content of the workshop and decision support
tools was developed for physician participants and training manuals for the co-trainers
Mode of delivery: interactive workshops led by 2 study principal investigators (or co-
trainers) and conducted face-to-face in a group format, and using videos and group
exercises
Duration and intensity: DECISION+: 3 x 3 3-hour interactive workshops, reminders
and feedback conducted over a 4- to 6-month period
Comparator: Usual care (delayed exposure to the DECISION+ intervention)
Outcomes Primary: decision about using antibiotics (immediate use, delayed use or no use) (GP/
patient; self administered questionnaire)
Secondary:
Perception of the quality of the decision (GP/patient; single item on a 10-point Likert
scale; self administered questionnaire)
Decisional conflict (GP/patient; Decisional Conflict Scale)
Patients’ intention to engage in SDM in future consultations concerning antibiotics for
ARIs (3-item, 7-point Likert scale; self administered questionnaire)
GPs’ intentions to engage in SDM and comply with clinical practice guidelines regarding
prescribing antibiotics for ARIs (3-item, 7-point Likert scale)
Decision Regret Scale (patients; telephone interview; 2 weeks following consultation)
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Perception of health changes since the consultation (patients; telephone interview; 2
weeks following consultation)
Number of prescriptions filled by patients covered by Quebec’s public drug insurance
plan (Regie de l’Assurance-Maladie du Quebec medication claims database) (during the
3 months preceding baseline and during the 3 months after FPs in the experimental
group were exposed to DECISION+)
Script concordance test (probes whether respondents’ knowledge is efficiently organised
to take appropriate clinical action by placing respondents in written, but authentic, clin-
ical situations in which they must interpret data to make decisions. It measures the con-
cordance between respondents’ scripts and the scripts of a panel of experts (administered
to GPs at each data collection point)
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: yes
Trial registration: not reported
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A
biostatistician simultaneously randomised
all FMGs using Internet-based software
Allocation concealment (selection bias) High risk A biostatistician allocated FMGs to
groups using Internet-based software.
There was concealed allocation of the Fam-
ily Medicine Groups, but not the family
physicians
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (multiple-component, con-
tinuing professional development pro-
gramme in shared decision making)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Codes were attributed to the trial groups
and the bio-statistician analysed the data
blindly. Team members accessed the codes
only after having completed the analyses
and interpreting the results
Incomplete outcome data (attrition bias)
All outcomes
Low risk 4 FMGs randomised to intervention (2;
GPs = 18; patients = 245) or control groups
(2; GPs = 15; patients = 214). 3/33 (9%)
GPs dropped out of the trial 20/245 pa-
tients in the intervention group and 14/
214 controls could not be contacted over
the 2-week follow-up
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Selective reporting (reporting bias) Low risk All indicated outcomes reported. Published
trial protocol
Other bias Low risk Sample size (power) calculation: no
Primary analysis was ITT
Légaré 2012
Methods Study design: cluster-randomised controlled trial
Unit of randomisation: family practice teaching units
Trial duration: July 2010 to April 2011
Recruitment: the network of 12 family practice teaching units in 6 regions of Quebec,
Canada, were randomised to intervention (6) or control (6) groups
Methods of data collection: following the consultation, patients and GPs independently
completed self administered questionnaires (primary and secondary outcomes). 2 weeks
later, a telephone follow-up interview was conducted by a research assistant (secondary
outcomes)
Data collection time points: immediately following consultation and 14 days
Participants GPs, including physician teachers and residents, who provide care in the walk-in clinics of
the 12 family practice teaching units. GPs participating in the pilot trial (Légaré 2011) or
those not expecting to practice in the teaching unit during the trial period were excluded.
Patients with symptoms suggestive of an ARI were recruited by a research assistant in
the waiting room prior to consultation with a physician. Eligible patients were adults
(and children who were accompanied by a parent/legal guardian) with a diagnosis of
ARI (e.g. bronchitis, otitis media, pharyngitis or rhinosinusitis) and for which the use
of antibiotics was subsequently considered either by the patient or physician during the
visit. The patient, parent or legal guardian had to be able to read, understand and write
French
Interventions Brief intervention name: DECISION+2 shared decision making program
Recipients: GPs
Providers: trained facilitators
Health professional components: an online tutorial comprised of 5 modules addressing
key components of the clinical decision making process about antibiotic treatment for
ARI in primary care: introduction to shared decision making and ARIs, estimating
diagnostic probabilities forARIs, therapeutic options, effective strategies to communicate
risk and benefits, identify patients’ values and preferences; and use of decision support
tools that promote shared decision making. Participants had 1 month to complete the
online tutorial. The on-site facilitator-led interactive workshop aimed to help physicians
review and integrate the concepts they acquired during the online training
Patient components: decision support tools
Materials: both the online tutorial and workshop included videos, exercises and decision
aids to help physicians communicate to their patients the probability of a bacterial acute
respiratory infection and the benefits and harms associated with the use of antibiotics
Mode of delivery: online tutorial and facilitator-led interactive workshop
Duration and intensity: 2-hour online tutorial followed by a 2-hour on-site interactive
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workshop
Comparator: usual care
Outcomes Primary: proportion of patients who decided to use antibiotics immediately after con-
sultation (GP and patient self administered questionnaire)
Secondary: decisional conflict (GP/patient; Decisional Conflict Scale)
Perception that shared decision making occurred (GP/patient; modified Control Prefer-
ence Scale)
Quality of decision made (GP/patient; single question Likert scale)
Adherence to the decision (patient; single-item asking if decision made was maintained)
Repeat consultation (for the same reason) (patient)
Decisional Regret (patient; Decisional regret Scale)
Quality of life (patient; SF-12)
Intention to engage in SDM in future consultations regarding the use of antibiotics for
ARIs (patients; questions based on Theory of Planned Behaviour)
Intentions to engage in shared decision making (GP)
Intention to adhere to clinical practice guidelines (GP)
Preferred role in decision making (Control Preference Scale)
Notes Funding: yes
Conflict of interest: none disclosed
Published trial protocol: yes
Trial registration: yes
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A biostatistician used Internet-based soft-
ware to simultaneously randomise all 12
family practice teaching units to either
the intervention group (DECISION+2) or
control group. The teaching units were
stratified according to rural or urban loca-
tion
Allocation concealment (selection bias) Unclear risk The family practice teaching unites were
recruited prior to randomisation, but it is
not clear when the physicians in the units
were recruited
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (due to the nature of the in-
tervention and the self administered out-
comes)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Statistical analysis was performed by a
statistician who was unaware of the teach-
ing unit allocations
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Incomplete outcome data (attrition bias)
All outcomes
Low risk 12 family practice teaching units ran-
domised; 9 participated in the study and all
clusters completed the trial
Selective reporting (reporting bias) Low risk All indicated outcome reported. Prospec-
tive trial registration. Published trial proto-
col
Other bias Unclear risk Sample size calculation: yes
ITT or per protocol analysis: not stated
Welschen 2004
Methods Study design: cluster-randomised controlled trial
Unit of randomisation: GP peer review group
Trial duration: 2000 to 2002
Recruitment: general practitioners’ (GP) peer review groups, with collaborating phar-
macists (which aim to promote rational prescribing through audit and feedback), in the
region of Utrecht, Netherlands, if the group consisted of ≥ 4 GPs and all agreed to
participate
Methods of data collection: during a 3-week period during 2000 and 2001
Data collection time points: index consultation
Length of follow-up: nil
Participants Primary care setting type: recruited from general practitioner (GP) peer review groups
General practitioners: 100 GPs
Patients: all registered patients presenting with acute symptoms of the respiratory tract
*Relatively low prescription rates in the Netherlands
Interventions Brief intervention name: multiple intervention
Recipients: GPs and patients
Providers: GP peer facilitators
Health professional components:
a) Group education meeting (jointly led a GP and pharmacist in each peer review group)
included a review of previous years claims data, discussion of evidence-based medicine
and communication of evidence for treatment benefit and risk to inform group consensus
about the indication and first choice of antibiotics per indication (AOM, sinusitis, ton-
sillitis and acute cough); communication skills training (how to explore patients’ worries
and expectations and to inform patients about the natural course of the symptoms, self
medication and alarm symptoms). GPs received a summary of their group’s guidelines
by mail 1 week after the meeting, and received the results of the baseline measurement
(to reinforce the consensus reached) after 2 months
b) Monitoring and feedback on prescribing behaviour (6 months post-intervention)
based on insurance claims data comparing the period after the intervention (March to
May 2001) with the same period before the intervention (March toMay 2000). Volumes
of different kinds of antibiotics and the extent to which prescribed antibiotics were in
line with the consensus about first choice antibiotics were presented at practice level
c) Group education for assistants of GPs and pharmacists attended a 2-hour group
49Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Welschen 2004 (Continued)
education session informing them about Dutch guidelines for GPs, followed by skills
training in educating patients
Patient components: education material for patients consisted of a brochure and accom-
panying posters (also translated into Turkish and Arabic) available in waiting rooms of
intervention group general practices, pharmacies and municipal health services, aiming
to inform patients about the self limiting character of most respiratory tract symptoms,
self medication and serious symptoms (“alarm signals”) necessitating a consultation with
the GP
Materials: consensus guidelines for GPs and education material for patients
Mode of delivery: GP and pharmacist-led group education meeting for GPs and assis-
tants, and patient education brochure and posters
Duration and intensity: 1 x group education meetings for GPs (duration not stated) and
1 x 2-hour group education meetings for assistants
Comparator: usual care
Outcomes Primary: proportion of practice encounters for acute symptoms of the respiratory tract
for which antibiotics were prescribed (patient records)
Patient satisfaction (self reported questionnaire; 1 = very dissatisfied to 5 = very satisfied)
Secondary: administrative claims data (from regional health insurance company, Agis,
over the period 2000 to 2002) (March to May, 2000 and March to May, 2001)
Notes Funding: yes
Conflict of interest: none declared
Published trial protocol: not reported
Trial registration: not reported
Ethics approval: yes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The 12 peer review groups were allocated
to groups A or B. All possible composi-
tions of groups A and B were considered
and the option chosen of those groups re-
sulting in comparability between group A
and B in groups with a high or low vol-
ume of antibiotic prescribing (above or be-
low the median), rural or urban working
groups, and number of general practition-
ers per group (above or below the median)
. MMK, who was blinded to the composi-
tion of the groups, flipped a coin to deter-
mine whether group A became the inter-
vention or control group
Allocation concealment (selection bias) Low risk Not stated. However, practices recruited
prior to randomisation
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible (multiple intervention)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Research assistants blinded to the interven-
tion status of the practices extracted infor-
mation from patient records (age, sex, diag-
noses, antibiotic prescriptions and referrals
to hospital doctors)
Patient satisfaction questionnaires returned
directly to the investigators without being
shown to the GP
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of the 42 of 48 peer-review groups in the
Utrecht region that were invited to partic-
ipate, 30 groups refused or were unable to
participate. The 12 remaining peer-review
groups were randomised to intervention (6
groups, 46 GPs) or control (6 groups, 54
GPs). All clusters and 89/100 GPs com-
pleted the study (intervention = 42, control
= 49), with loss to follow-up due to retire-
ment (n = 1), removal outside the region (n
= 3), illness (n = 3), motivational problems
(n = 2) or technical problems (n = 2)
Selective reporting (reporting bias) Low risk All indicative results reported
Other bias Low risk Sample size (power) calculation: yes
ITT of per protocol analysis: yes
AOM: acute otitis media
ARI: acute respiratory infection
COPD: chronic obstructive pulmonary disease
CRP: C-reactive protein
FP: family physician
GP: general practitioner
ITT: intention-to-treat
LRTI: lower respiratory tract infection
n/a: not applicable
OTC: over-the-counter
RCT: randomised controlled trial
RTI: respiratory tract infection
SDM: shared decision making
URTI: upper respiratory tract infection
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bourgeois 2010 Shared decision making not explicit or inferred
Gonzales 2013 Shared decision making not explicit or inferred
Pshetizky 2003 Shared decision making not explicit or inferred
Regev-Yochay 2011 Shared decision making not explicit or inferred
Samore 2005 Shared decision making not explicit or inferred
Taylor 2005 Shared decision making not explicit or inferred
Characteristics of ongoing studies [ordered by study ID]
Altiner 2012
Trial name or title Converting habits of antibiotic prescribing for respiratory tract infections in German primary care - the
cluster-randomised controlled (CHANGE-2) trial
Methods 3-arm cluster-randomised controlled trial
Participants GPs (n = 94) or practice-based paediatricians (n = 94) and their patients (~ 30,000 children and adults) who
consult in general practices located in 2 German regions (Baden-Württemberg and Mecklenburg-Western
Pomerania) for an ARI
Interventions Communication training versus communication training and point of care testing (C-reactive protein and
rapid antigen detection testing) versus control
Outcomes Primary: physician antibiotic prescription rate for ARI at 2-year follow-up (post-intervention) derived from
data of the statutory health insurance company
Secondary:
1. Re-consultation rate
2. Use of medical services
3. Hospital admissions
Starting date GP and paediatrician recruitment commenced October 2012; patient recruitment over 3 successive winter
periods
Contact information Prof Attila Altiner; Institute for General Practice, Rostock University Medical Center; POB 100888; Rostock
18055 Germany
Phone: +49 (0)381 494 2481
Fax: +49 (0)381 494 2482
Email: ifa.sekretariat@med.uni-rostock.de
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Notes -
ARI: acute respiratory infection
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D A T A A N D A N A L Y S E S
Comparison 1. Shared decision making versus usual care (control)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotics prescribed, dispensed
or decision to use (short-term,
index consultation to ≤ 6
weeks)
8 10172 Risk Ratio (Random, 95% CI) 0.61 [0.55, 0.68]
2 Antibiotics prescribed or
dispensed (longer-term, ≥ 12
months)
3 481588 Risk Ratio (Random, 95% CI) 0.74 [0.49, 1.11]
3 Antibiotic prescriptions (index
consultation) (adjusted odds
ratio)
3 3244 Odds Ratio (Random, 95% CI) 0.44 [0.26, 0.75]
4 Antibiotic prescriptions (index
consultation) (adjusted risk
ratio)
2 4623 Risk Ratio (Random, 95% CI) 0.64 [0.49, 0.84]
5 Antibiotic prescriptions (index
consultation or population rate
per unit of time) (adjusted risk
difference)
4 481807 Mean Difference (Random, 95% CI) -18.44 [-27.24, -9.
65]
6 Number or rate of
re-consultations (risk ratio)
4 1861 Risk Ratio (Random, 95% CI) 0.87 [0.74, 1.03]
7 Patient satisfaction with the
consultation
2 1052 Odds Ratio (Random, 95% CI) 0.86 [0.57, 1.30]
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Analysis 1.1. Comparison 1 Shared decision making versus usual care (control), Outcome 1 Antibiotics
prescribed, dispensed or decision to use (short-term, index consultation to ≤ 6 weeks).
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 1 Antibiotics prescribed, dispensed or decision to use (short-term, index consultation to≤ 6 weeks)
Study or subgroup
Shared
decision
making Usual care log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Francis 2009 (1) 256 272 -0.7867 (0.4212) 1.8 % 0.46 [ 0.20, 1.04 ]
Briel 2006 (2) 259 293 -0.1518 (0.2619) 4.8 % 0.86 [ 0.51, 1.44 ]
L gar 2012 (3) 181 178 -0.6931 (0.2606) 4.8 % 0.50 [ 0.30, 0.83 ]
L gar 2011 (4) 81 70 -0.3738 (0.204) 7.9 % 0.69 [ 0.46, 1.03 ]
Cals 2009 (5) 201 230 -0.6846 (0.19) 9.1 % 0.50 [ 0.35, 0.73 ]
Altiner 2007 (6) 1021 1143 -0.6983 (0.1666) 11.8 % 0.50 [ 0.36, 0.69 ]
Little 2013 (7) 2332 1932 -0.3711 (0.1251) 20.9 % 0.69 [ 0.54, 0.88 ]
Welschen 2004 (8) 905 818 -0.4806 (0.0917) 38.9 % 0.62 [ 0.52, 0.74 ]
Total (95% CI) 5236 4936 100.0 % 0.61 [ 0.55, 0.68 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.62, df = 7 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 8.63 (P < 0.00001)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Shared decision making Usual care
(1) Reported intra-class correlation co-efficient (ICC) = 0.24. Design effect and effective sample size calculated.
(2) Reported intra-class correlation co-efficient (ICC) = 0.04. Design effect and effective sample size calculated. Actual sample denomiator used to calculate risk ratio.
Actual sample denominators reported in forest plot.
(3) Adjusted for cluster design, baseline values and patient age group (for analyses at teaching unit and physician levels).
(4) Reported intra-class correlation co-efficient (ICC) = 0.02. Design effect and effective sample size calculated.
(5) Reported intra-class correlation co-efficient (ICC) = 0.12. Design effect and effective sample size used to calculate risk ratio. Actual sample denominators reported in
forest plot.
(6) Reported intra-class correlation co-efficient (ICC) = 0.20. Design effect and effective sample size used to calculate risk ratio. Actual sample denominators reported in
forest plot.
(7) Adjusted for baseline prescribing and clustering by physician and practice, age, smoking, sex, major cardiovascular or respiratory comorbidity, baseline symptoms,
crepitations, wheeze, pulse higher than 100 beats per minute, temperature higher than37.8 degrees Celcius, respiratory rate, blood pressure, physician’s rating of severity,
and duration of cough.
(8) Reported intra-class correlation co-efficient (ICC) = 0.09. Design effect and effective sample size used to calculate risk ratio. Actual sample denominators reported in
forest plot.
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Analysis 1.2. Comparison 1 Shared decision making versus usual care (control), Outcome 2 Antibiotics
prescribed or dispensed (longer-term, ≥ 12 months).
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 2 Antibiotics prescribed or dispensed (longer-term,≥ 12 months)
Study or subgroup
Shared
decision
making Usual care log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Cals 2013 (1) 178 201 -0.3817 (0.2188) 27.2 % 0.68 [ 0.44, 1.05 ]
Altiner 2007 (2) 787 920 -0.5625 (0.1384) 33.4 % 0.57 [ 0.43, 0.75 ]
Butler 2012 (3) 239802 239700 -0.0254 (0.0053) 39.4 % 0.97 [ 0.96, 0.99 ]
Total (95% CI) 240767 240821 100.0 % 0.74 [ 0.49, 1.11 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 17.68, df = 2 (P = 0.00015); I2 =89%
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Shared decision making Usual care
(1) Design effect (2.08) imputed from Cals (2009). Effective sample size calculated by imputing intra-class correlation co-efficient reported by Cals 2009 (0.12). Actual
sample denominators reported in forest plot.
(2) Reported intra-class correlation co-efficient (ICC) = 0.20. Design effect and effective sample size used to calculate risk ratio. Actual sample denominators reported in
forest plot.
(3) Numerators and denominators estimated from dispensing rates per 1000 registered patients and reported mean list sizes at baseline, respectively. Effective sample
size calculated by imputing design effect at 12 months (6.9) reported by Altiner (2007).
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Analysis 1.3. Comparison 1 Shared decision making versus usual care (control), Outcome 3 Antibiotic
prescriptions (index consultation) (adjusted odds ratio).
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 3 Antibiotic prescriptions (index consultation) (adjusted odds ratio)
Study or subgroup
Shared
decision
making Usual care log [Odds Ratio] Odds Ratio Weight Odds Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Briel 2006 (1) 259 293 -0.1508 (0.3906) 26.7 % 0.86 [ 0.40, 1.85 ]
Francis 2009 (2) 256 272 -1.2379 (0.3716) 28.1 % 0.29 [ 0.14, 0.60 ]
Altiner 2007 (3) 1021 1143 -0.9676 (0.1936) 45.2 % 0.38 [ 0.26, 0.56 ]
Total (95% CI) 1536 1708 100.0 % 0.44 [ 0.26, 0.75 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 4.62, df = 2 (P = 0.10); I2 =57%
Test for overall effect: Z = 3.02 (P = 0.0025)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Shared decision making Usual care
(1) Logistic regression with random effect for each cluster and patient covariates (age, sex, education, days with restriction at baseline).
(2) Odds ratio from multilevel modelling.
(3) Adjusted for patient’s disease severity, average practice severity (severity of the disease rated by the GP), patients having fever (compared with no fever), and frequency
of fever in practice.
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Analysis 1.4. Comparison 1 Shared decision making versus usual care (control), Outcome 4 Antibiotic
prescriptions (index consultation) (adjusted risk ratio).
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 4 Antibiotic prescriptions (index consultation) (adjusted risk ratio)
Study or subgroup
Shared
decision
making Usual care log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
L gar 2012 (1) 181 178 -0.6931 (0.2606) 24.8 % 0.50 [ 0.30, 0.83 ]
Little 2013 (2) 2332 1932 -0.3711 (0.1251) 75.2 % 0.69 [ 0.54, 0.88 ]
Total (95% CI) 2513 2110 100.0 % 0.64 [ 0.49, 0.84 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.24, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 3.24 (P = 0.0012)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Shared decision making Usual care
(1) Adjusted for cluster design, baseline values and patient age group (for analyses at teaching-unit and physician levels).
(2) Adjusted for baseline prescribing and clustering by physician and practice, age, smoking, sex, major cardiovascular or respiratory comorbidity, baseline symptoms,
crepitations, wheeze, pulse higher than 100 beats per minute, temperature higher than 37.8 degrees celcius, respiratory rate, blood pressure, physician’s rating of severity,
and duration of cough.
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Analysis 1.5. Comparison 1 Shared decision making versus usual care (control), Outcome 5 Antibiotic
prescriptions (index consultation or population rate per unit of time) (adjusted risk difference).
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 5 Antibiotic prescriptions (index consultation or population rate per unit of time) (adjusted risk difference)
Study or subgroup
Shared
decision
making Usual care Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Butler 2012 (1) 239802 239700 -26.1 (12.3363) 11.1 % -26.10 [ -50.28, -1.92 ]
Cals 2009 (2) 201 230 -26.1 (5.6518) 33.0 % -26.10 [ -37.18, -15.02 ]
L gar 2011 (3) 81 70 -16 (9.0754) 18.1 % -16.00 [ -33.79, 1.79 ]
Welschen 2004 (4) 905 818 -10.7 (4.898) 37.9 % -10.70 [ -20.30, -1.10 ]
Total (95% CI) 240989 240818 100.0 % -18.44 [ -27.24, -9.65 ]
Heterogeneity: Tau2 = 29.17; Chi2 = 4.75, df = 3 (P = 0.19); I2 =37%
Test for overall effect: Z = 4.11 (P = 0.000040)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Shared decision making Usual care
(1) Analysis of covariance with the previous year’s prescribing as a covariate.
(2) Crude 95%CI calculated and inflated for clustering by using standard deviation inflated by variance inflation factor. P value calculated from second order penalised
quasi-likelihood multilevel logistic regression model for variance at general practitioner and practice level (random intercept at practice and general practitioner level).
Models included both interventions and interaction term of intervention.
(3) All P values adjusted for baseline values and the study’s cluster design.
(4) Intervention effect in multilevel analysis.
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Analysis 1.6. Comparison 1 Shared decision making versus usual care (control), Outcome 6 Number or
rate of re-consultations (risk ratio).
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 6 Number or rate of re-consultations (risk ratio)
Study or subgroup
Shared
decision
making Usual care log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Francis 2009 (1) 256 272 -0.2252 (0.3535) 5.8 % 0.80 [ 0.40, 1.60 ]
L gar 2012 (2) 181 178 0.2624 (0.3158) 7.3 % 1.30 [ 0.70, 2.41 ]
Cals 2009 (3) 201 230 -0.288 (0.1492) 32.7 % 0.75 [ 0.56, 1.00 ]
Briel 2006 (4) 253 290 -0.0901 (0.116) 54.1 % 0.91 [ 0.73, 1.15 ]
Total (95% CI) 891 970 100.0 % 0.87 [ 0.74, 1.03 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.85, df = 3 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Shared decision making Usual care
(1) Reported intra-class correlation co-efficient (ICC) = 0.06. Design effect and effective sample size calculated.
(2) Adjusted for cluster design and baseline values.
(3) Reported intra-class correlation co-efficient (ICC) = 0.01. Design effect and effective sample size calculated.
(4) Reported intra-class correlation co-efficient (ICC) = 0.04. Design effect and effective sample size calculated.
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Analysis 1.7. Comparison 1 Shared decision making versus usual care (control), Outcome 7 Patient
satisfaction with the consultation.
Review: Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
Comparison: 1 Shared decision making versus usual care (control)
Outcome: 7 Patient satisfaction with the consultation
Study or subgroup
Shared
decision
making Usual care log [Odds Ratio] Odds Ratio Weight Odds Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Francis 2009 (1) 246 263 -0.4463 (0.338) 34.3 % 0.64 [ 0.33, 1.24 ]
Briel 2006 (2) 253 290 0 (0.2277) 65.7 % 1.00 [ 0.64, 1.56 ]
Total (95% CI) 499 553 100.0 % 0.86 [ 0.57, 1.30 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 1.20, df = 1 (P = 0.27); I2 =17%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Shared decision making Usual care
(1) Odds Ration from multilevel modelling
(2) Proportion of patients with a maximum score of 70 (out of 70) used due to highly skewed scores. Logistic regression with random effect for each cluster and patient
covariates (age, sex, education, days with restricitons at baseline.
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Table 1. TIDieR intervention summary (Hoffmann 2014)
Au-
thor
year
Brief
name
Recip-
ient
Why What
(mate-
rials)
What
(pro-
ce-
dures)
Who
pro-
vided
How Where When
and
how
much
Tailor-
ing
Mod-
ifica-
tion of
inter-
ven-
tion
through-
out
trial
Strate-
gies to
im-
prove
or
main-
tain
inter-
ven-
tion fi-
delity
Ex-
tent of
inter-
ven-
tion fi-
delity
Al-
tiner
2007
Com-
plex
GP
peer-
led ed-
GPs
and
pa-
tients
Fo-
cused
on
com-
muni-
Peers
used
a semi-
struc-
tured
GP
peer-
led
out-
reach
5 prac-
tising
GPs
and
teach-
Face-
to-face
out-
reach
visits
GP
clinics
during
normal
work-
1 out-
reach
visit
per-
formed
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
51/52
GPs re-
ceived
inter-
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
uca-
tional
inter-
ven-
tion
cation
within
a con-
sulta-
tion
and
the
mutual
discor-
dance
be-
tween
pa-
tients’
expec-
tations
and
doc-
tors’
per-
ceived
patient
ex-
pecta-
tions,
em-
power-
ing pa-
tients
to raise
the
issue
within
the
con-
sulta-
tion.
By ’in-
form-
ing’
both
sides
in the
con-
sulta-
tion,
it is
dia-
logue
script
for
out-
reach
visits
Patient
mate-
rials
(leaflet
and
poster)
pro-
vided
in
wait-
ing
room
pri-
marily
fo-
cused
on the
pa-
tients’
role
doc-
tor-
patient
’an-
tibiotic
mis-
under-
stand-
ing’
and
brief
evi-
dence-
based
infor-
mation
on
acute
cough
visits.
Peers
were
trained
to
explore
GPs’
’op-
posite’
mo-
tiva-
tional
back-
ground
to
address
their
beliefs
and
atti-
tudes.
GPs
were
moti-
vated
to
explore
patient
expec-
tations
and
de-
mands,
to
elicit
anxi-
eties
and
make
antibi-
otic
pre-
scrib-
ing a
subject
in the
ing
aca-
demics
in the
lead
au-
thors’
depart-
ment
(2
female,
33
to 63
years
of age);
trained
in 3
ses-
sions
for
out-
reach
visits
to GPs ing
hours
per GP
(du-
ration
not
speci-
fied)
ven-
tion
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
hoped
that
doc-
tors
and
pa-
tients
would
openly
talk
about
the
issue
and
thus
reduce
unnec-
essary
antibi-
otic
pre-
scrip-
tions
and
antibi-
otics
con-
sulta-
tion
Patient
mate-
rials
were
aimed
at em-
power-
ing pa-
tients
to raise
and
clarify
issues
within
the
con-
sulta-
tion
Briel
2006
Brief
train-
ing
pro-
gramme
in pa-
tient-
cen-
tred
com-
muni-
cation
GPs Fo-
cused
on
teach-
ing
GPs
how to
under-
stand
and
modify
pa-
tients’
con-
cepts
and
beliefs
about
the
use of
antibi-
otics
for
ARIs.
Evi-
dence-
based
guide-
lines
for di-
agnosis
and
treat-
ment
of
ARIs
(up-
dated,
locally
adapted
and re-
viewed
by
local
ex-
perts)
dis-
tributed
GPs
were
trained
in ele-
ments
of
active
listen-
ing,
to re-
spond
to
emo-
tional
cues,
and to
tailor
infor-
mation
given
to pa-
tients.
Physi-
cians
Not
speci-
fied
Semi-
nar in
small
groups
(num-
ber not
spec-
ified)
and
per-
sonal
feed-
back
by tele-
phone
prior
to the
start
of the
trial.
Evi-
dence-
based
Not
speci-
fied
Atten-
dance
at 1 x
6-hour
sem-
inar
and 1 x
2-hour
tele-
phone
call to
give
per-
sonal
feed-
back
prior
to the
trial
start
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
GPs
were
intro-
duced
to a
model
(Prochaska
1992)
for
iden-
tifying
pa-
tients’
atti-
tude
and
readi-
ness
for be-
haviour
change
as a
book-
let
[URL
pro-
vided
is no
longer
active]
used a
model
were
intro-
duced
to a
model
(Prochaska
1992)
to
iden-
tify pa-
tients’
atti-
tude
and
readi-
ness
for be-
haviour
change
guide-
lines
were
dis-
tributed
as a
book-
let
Butler
2012
Multi-
faceted
flexible
blended
learn-
ing ap-
proach
for
clini-
cians
GPs
and
nurse
practi-
tioners
Blended
learn-
ing
expe-
rience
to de-
velop
clini-
cians’
sense
of the
impor-
tance
about
change
and
their
confi-
dence
in their
ability
to
achieve
change
based
Sum-
maries
of re-
search
evi-
dence
and
guide-
lines,
web-
based
mod-
ules
using
video-
rich
ma-
terial
pre-
senting
novel
com-
muni-
cation
skills,
and a
Inter-
ven-
tion
consist
of 7
com-
po-
nents:
experi-
ential
learn-
ing,
up-
dated
sum-
maries
of re-
search
evi-
dence
and
guide-
lines;
web-
based
A facil-
itator
con-
ducted
the
face-
to-face
semi-
nar
Inter-
ven-
tion
con-
sisted
of 7
parts
(5
online
mod-
ules, 1
face-
to-face
sem-
inar
and 1
facili-
tator-
led
prac-
tice-
based
semi-
nar)
The
face-
to-face
and
facili-
tator-
led
sem-
inars
were
pre-
sented
at the
general
prac-
tice
7 com-
po-
nents
(5
online,
1 face-
to-face
and 1
facili-
tator-
led
prac-
tice-
based
semi-
nar)
A
booster
mod-
ule (6
to 8
months
after
com-
Inter-
ven-
tion
was
flexible
so clin-
icians
could
access
the
online
com-
po-
nents
and
try out
new
skills
with
their
pa-
tients
at their
conve-
Not
de-
scribed
Not
de-
scribed
138/
139
com-
pleted
all
online
train-
ing
and
up-
loaded
de-
scrip-
tions
of con-
sulta-
tions
for the
port-
folio
tasks;
129/
139 at-
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
on
Social
Learn-
ing
The-
ory
Clin-
icians
re-
flected
on
prac-
tice-
level
antibi-
otic
dis-
pens-
ing
and
resis-
tance
data,
re-
flected
on
own
clinical
prac-
tice
(con-
text-
bound
learn-
ing)
, and
were
trained
in
novel
com-
muni-
cation
skills
de-
rived
from
web-
based
forum
to
share
experi-
ences
and
views
(see
www.stemmingthetide.org
for on-
line
com-
po-
nent)
learn-
ing in
novel
com-
muni-
cation
skills;
prac-
tising
con-
sulting
skills
in rou-
tine
care;
facili-
tator-
led
prac-
tice-
based
semi-
nar on
prac-
tice-
level
data
on an-
tibiotic
pre-
scrib-
ing
and
resis-
tance;
reflec-
tions
on
own
clinical
prac-
tice,
and a
web-
based
forum
pletion
of
initial
train-
ing)
rein-
forced
these
skills
nience tended
the
prac-
tice-
based
semi-
nars;
76/
139
com-
pleted
the op-
tional
booster
session
at 6
months;
11/
139
en-
tered
new
threads
on the
online
forum
with
81
posts
and
1485
view-
ings of
posts
and
threads
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
prin-
ciples
of mo-
tiva-
tional
inter-
view-
ing
to
share
experi-
ences
and
views
Cals
2009
En-
hanced
com-
muni-
cation
skills
train-
ing
GPs Fo-
cused
on
infor-
mation
ex-
change
based
on the
elicit-
pro-
vide-
elicit
frame-
work
from
coun-
selling
in be-
haviour
change
-
explor-
ing pa-
tients’
fears
and ex-
pecta-
tions,
pa-
tients’
opin-
ion on
antibi-
otics
and
outlin-
ing the
Pre
and
post-
work-
shop
tran-
scripts
of sim-
ulated
pa-
tients
Brief
con-
text-
learn-
ing
based
work-
shop in
small
groups
(5 to 8
GPs)
, pre-
ceded
and
fol-
lowed
by
prac-
tice-
based
con-
sulta-
tions
with
simu-
lated
pa-
tients.
GPs
re-
flected
on
own
tran-
scripts
of con-
Expe-
ri-
enced
mod-
erator
to lead
semi-
nars
Brief
work-
shop
(5 to 8
GPs)
, pre-
ceded
and
fol-
lowed
by
prac-
tice-
based
con-
sulta-
tion
with
simu-
lated
pa-
tients
Gen-
eral
prac-
tice
1 x 2-
hour
mod-
erator-
led
small
groups
work-
shop,
pre-
ceded
and
fol-
lowed
by
prac-
tice-
based
con-
sulta-
tion
with
simu-
lated
pa-
tients
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
66%
of pa-
tients
re-
cruited
by GPs
allo-
cated
to
train-
ing in
en-
hanced
com-
muni-
cation
skills
re-
called
their
GP’s
use at
least
3 of 4
spe-
cific
com-
muni-
cation
skills
com-
pared
with
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
natural
dura-
tion of
cough
in
lower
respi-
ratory
tract
infec-
tions
sulta-
tions
with
simu-
lated
pa-
tients,
which
were
also
peer-
re-
viewed
by col-
leagues
19%
in the
no
train-
ing
group
Fran-
cis
2009
Inter-
active
book-
let for
parents
and
clini-
cian
train-
ing in
its use
GPs
and
pa-
tients
Fo-
cused
on spe-
cific
com-
muni-
cation
skills,
such as
explor-
ing
par-
ent’s
main
con-
cerns,
asking
about
their
ex-
pecta-
tions,
and
dis-
cussing
prog-
nosis,
treat-
ment
op-
tions
and
8-page
book-
let
(now
at
www.whenshouldIworry.com
);
online
train-
ing in
use
of the
book-
let in-
cluded
videos
to
demon-
strate
use
of the
book-
let
within
a con-
sulta-
tion, as
well as
audio
feeds,
Book-
let
given
to
parents
to use
in the
con-
sulta-
tion
and as
a take-
home
re-
source
(no
further
details
pro-
vided)
Online
train-
ing on
the use
of the
book-
let was
pro-
vided
to
GPs:
N/A
(online
train-
ing)
Parents
used
the
book-
let
face-
to-face
in the
con-
sulta-
tion
with
GPs
and
took it
home;
GP
train-
ing in
use of
book-
let was
online
Gen-
eral
prac-
tice;
par-
ents’
homes
1 x 40-
minute
online
train-
ing
mod-
ule
Not
de-
scribed
Not
de-
scribed
Online
clin-
ician
train-
ing
moni-
tored
through
study
web-
site:
whether
a GP
has
logged
on to
the
site,
how
much
time
spent
on it
and
which
pages
were
viewed
Stated
that
treat-
ment
fidelity
was
not
mea-
sured
so that
asses-
sors
could
remain
blind
to the
study
group
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
reasons
that
should
prompt
re-con-
sulta-
tion
pic-
tures
and
links
to
study
mate-
rials
[orig-
inal
URL
no
longer
active]
de-
scrib-
ing the
con-
tent
and
aims
of the
book-
let,
and
en-
cour-
aging
use
within
the
con-
sulta-
tion to
facil-
itate
use of
spe-
cific
com-
muni-
cation
skills
Légaré
2012
Shared
deci-
sion
mak-
ing
train-
ing
pro-
gram
(DE-
CI-
SION+2)
Family
physi-
cians
(in-
clud-
ing
teach-
ers and
resi-
dents)
A
shared
deci-
sion
mak-
ing
train-
ing
pro-
gram
that
aimed
to help
physi-
cians
com-
mu-
nicate
to pa-
Online
tuto-
rial
and
work-
shop
in-
cluded
videos,
exer-
cises
and
deci-
sion
aids to
help
physi-
cians
Online
self tu-
torial
com-
prising
5 mod-
ules 2-
hour
online
tuto-
rial fol-
lowed
by a
facili-
tator-
led on-
site
inter-
Trained
facili-
tators
On-
line tu-
torial
and
face-
to-face
work-
shop
Family
prac-
tice
teach-
ing
units
1 x 2-
hour
online
tuto-
rial,
fol-
lowed
by 1 x
2-hour
on-site
inter-
active
work-
shop.
Partic-
ipants
had 1
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
Of the
162
physi-
cians,
103
com-
pleted
both
the
online
tuto-
rial
and
work-
shop;
16
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
tients
the
proba-
bility
of a
bac-
terial
ARI
and
the
bene-
fits and
harms
asso-
ciated
with
the
use of
antibi-
otics
com-
muni-
cate to
their
pa-
tients
the
proba-
bility
of bac-
terial
ARIs
and
ben-
efits/
harms
of an-
tibiotic
use.
Deci-
sion
aids
were
avail-
able
in the
con-
sulta-
tion
rooms
in all
family
prac-
tice
teach-
ing
units
active
work-
shops
aimed
to help
physi-
cians
review
and in-
tegrate
con-
cepts
ac-
quired
during
online
train-
ing
month
to
com-
plete
the
pro-
gramme
com-
pleted
only
the
work-
shop;
15
only
the tu-
torial;
and 28
com-
pleted
none
of the
train-
ing
com-
po-
nents
Légaré
2011
Mul-
tiple-
com-
po-
nent,
con-
tin-
uing
profes-
sional
devel-
Family
medicine
groups
(physi-
cians
and
nurses)
Aimed
to help
family
physi-
cians
com-
mu-
nicate
to pa-
tients
the
Work-
shops
in-
cluded
videos
(sim-
ulated
con-
sulta-
tions
of
Inter-
active
work-
shops
and
related
mate-
rial, re-
minders
of ex-
pected
Trained
facili-
tators
Face-
to-face
work-
shop
Family
medicine
groups
3 x 3-
hour
inter-
active
work-
shops
and
related
mate-
rial, in
Not
de-
scribed
4 pilot
work-
shops
held
rather
than 3
as the
second
work-
shop
Not
de-
scribed
Not
de-
scribed
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
op-
ment
pro-
gram
in
shared
deci-
sion
mak-
ing
(DE-
CI-
SION+)
proba-
bility
of bac-
terial
ARI
and
bene-
fits and
harms
of an-
tibiotic
use
usual
care
and
SDM)
and ex-
ercises
(facil-
itators
and
barri-
ers to
SDM)
. GPs
trained
in the
use of
5 de-
cision
sup-
port
tools
using
video
exam-
ples
and
group
exer-
cises. A
book-
let
sum-
maris-
ing
work-
shop
con-
tent
pro-
vided
to
partici-
pants.
Post-
card
re-
minders
sent
be-
haviours
and
GP
feed-
back
on
agree-
ment
be-
tween
their
deci-
sional
con-
flict
and
that of
their
pa-
tients
addi-
tion
to re-
minders
of ex-
pected
be-
haviours
and
GP
feed-
back
on
agree-
ment
be-
tween
their
deci-
sional
con-
flict
and
that of
their
pa-
tients.
DECI-
SION+
con-
ducted
over
4 to 6
months
was re-
designed
and re-
piloted
after
feed-
back
on its
first
testing
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
Little
2013
Inter-
net-
based
train-
ing
in en-
hanced
com-
muni-
cation
skills
GPs Ratio-
nale
was
that
Inter-
net-
based
train-
ing
can be
more
widely
dis-
semi-
nated
than
face-
to-face
train-
ing.
Train-
ing fo-
cused
on
elicit-
ing pa-
tients’
expec-
tations
and
con-
cerns,
natural
disease
course,
treat-
ments,
agree-
ment
on a
man-
age-
ment
plan,
sum-
ming
Inter-
active
book-
let for
use by
GPs
within
con-
sulta-
tions
Train-
ing
sup-
ported
by
video
demon-
stra-
tions
of con-
sulta-
tion
tech-
niques
Online
mod-
ules
and an
inter-
active
book-
let for
use
within
con-
sulta-
tions.
(Group
prac-
tices
also
ap-
pointed
a lead
GP to
organ-
ise a
struc-
tured
meet-
ing on
pre-
scrib-
ing
issues)
N/A
(online
mod-
ules)
other
than
lead
GP at
each
prac-
tice to
organ-
ise a
meet-
ing
(not
spe-
cific
to just
this
arm of
the in-
terven-
tion
though)
Online
mod-
ules
(and
GP-led
struc-
tured
prac-
tice-
based
meet-
ing)
Gen-
eral
prac-
tice
Inter-
net
mod-
ules
com-
pleted
alone
or in a
group
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
94/
108
prac-
tices
(87%)
com-
pleted
the
com-
muni-
cation
train-
ing.
Mean
(SD)
time
spent
on the
web-
site
was 37
(29)
min-
utes
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
up and
guid-
ance
on
when
to re-
con-
sult
Welschen
2004
Group
edu-
cation
meet-
ing
with
con-
sensus
proce-
dure
and
com-
muni-
cation
skills
train-
ing
GPs/
phar-
ma-
cists
and
their
assis-
tants,
and
pa-
tients
GPs
dis-
cussed
evi-
dence
for an-
tibiotic
ben-
efit/
risk,
and
learned
com-
muni-
cation
tech-
niques
to
explore
pa-
tients’
expec-
tations
and
con-
cerns,
inform
about
natural
course
of
symp-
toms,
self-
medi-
cation
and
alarm
symp-
Group
con-
sensus
guide-
lines
and
patient
wait-
ing
room
mate-
rials
(poster/
leaflets)
Group
edu-
cation
meet-
ing
with
con-
sensus
proce-
dure,
with a
sum-
mary,
and
guide-
lines
mailed
1
month
later to
rein-
force
con-
sensus
reached;
feed-
back
on pre-
scrib-
ing be-
haviour
(post-
and
pre-in-
terven-
tion
insur-
ance
Jointly
led
by GP
and
phar-
macist
Group
edu-
cation
meet-
ing for
GPs
with
con-
sensus
proce-
dure
and
com-
muni-
cation
skills
train-
ing,
Group
edu-
cation
for
GPs’
and
phar-
ma-
cists’
assis-
tants,
moni-
toring
and
feed-
back
on pre-
scrib-
ing be-
Not
de-
scribed
1 x
group
edu-
cation
meet-
ing
with
con-
sensus
proce-
dure;
1 x 2-
hour
group
edu-
cation
session
for GP
and
phar-
ma-
cists’
assis-
tants;
moni-
toring
and
feed-
back
of pre-
scrib-
ing be-
haviour
at 6
months
post-
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
Not
de-
scribed
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Table 1. TIDieR intervention summary (Hoffmann 2014) (Continued)
toms.
Patient
edu-
cation
pro-
vided
infor-
mation
on the
self-
lim-
iting
nature
or
ARIs,
self-
medi-
cation
and
alarm
symp-
toms
requir-
ing re-
con-
sulta-
tion
claims
data)
and
prac-
tice-
level
report-
ing of
extent
pre-
scrib-
ing be-
haviours
aligned
with
con-
sensus
reached;
group
edu-
cation
session
for GP
and
phar-
ma-
cists
assis-
tants
(Dutch
guide-
lines
and
skills
train-
ing in
patient
educa-
tion)
; wait-
ing
room
edu-
cation
al ma-
terial
for pa-
tients
haviour,
and
patient
edu-
cation
mate-
rials
inter-
ven-
tion
ARI: acute respiratory infection
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GP: general practitioner
N/A: not applicable
Table 2. Antibiotic prescriptions per index consultation or population rate over time
Author Outcome Measurement
time point
Intervention
(n)
Control Effect
estimate
P value Notes
Adjusted odds
ratio (95%
CI)
Francis
(2009)
Antibiotics
prescribed at
the index con-
sultation
14 days (30 practices)
Patients = 50/
256 (19.5%)
(31 practices)
Pa-
tients = 111/
272 (40.8%)
0.29 (0.14 to
0.60)a
NR ICC = 0.24
Altiner
(2007)
Rate of
antibiotic pre-
scriptions (per
acute cough
and per GP)
6 weeks GPs = 42
Patients =
1021
GPs = 44
Patients =
1143
0.38 (0.26 to
0.56)b
< 0.001 ICC=0.20
12 months GPs = 28
Patients = 787
GPs = 33
Patients = 920
0.55 (0.38 to
0.80)b
0.002
Briel (2006) Uptake of
antibiotic pre-
scriptions
as reported by
pharmacists <
2 weeks after
the consulta-
tion
14 days GPs = 15
Patients = 259
GPs = 15
Patients = 293
0.86 (0.40 to
1.93)c
NR ICC = 0.04
Design effect = 1.6
Ad-
justed risk ra-
tio (95% CI)
Little (2013) Antibiotic
prescription
index consul-
tation
Practices = 61
Patients =
2332
Practices = 61
Patients =
1932
0.69 (0.54 to
0.87)d
< 0.0001 -
Légaré
(2012)
% pa-
tients who de-
cided to use
antibiotics im-
mediately af-
ter the consul-
tation
Index consul-
tation
Practice units
= 6
GPs = 77
Patients = 181
Practice units
= 6
GPs = 72
Patients = 178
0.50 (0.30 to
0.70)e
- -
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Table 2. Antibiotic prescriptions per index consultation or population rate over time (Continued)
Adjusted
risk difference
(95% CI)
Légaré
(2011)
% pa-
tients who de-
cided to use
antibiotics im-
mediately af-
ter the consul-
tation
Index consul-
tation
Medicine
groups = 2
GPs = 18
Patients = 81
Medicine
groups
GPs = 14
Patients = 70
-16 (-31 to 1)
f
0.08 -
Butler (2012) Total no. dis-
pensed
oral antibiotic
items
per 1000 reg-
istered pa-
tients for the
year after the
intervention
12-month pe-
riod
Practices
= 34 Patients =
7053
Practices
= 34 Patients =
7050
-4.2 (-0.6 to -
7.7)
0.02 -
Cals (2009) Antibiotic
prescribing at
the index con-
sultation
Index consul-
tation
n/N = 55/201
% crude (95%
CI)G
27.4 (25.6 to
36.6)
n/N = 123/
230
% crude (95%
CI)g
53.5 (43.8 to
63.2)
-26.1 (%
crude)
< 0.01h ICC = 0.12
Cals (2013) Proportion
of episodes of
respi-
ratory tract in-
fections dur-
ing follow-up
for which a
GP was seen
and that an-
tibiotics were
prescribed for
Mean
3.67 years fol-
low-up
n = 178
% (95% CI)
26.3 (20.6 to
32.0)
n = 201
% (95% CI)
39.1 (33.1 to
45.1)
-10.4i 0.02i -
Welschen
(2006)
% practice en-
coun-
ters for acute
symptoms
of the respira-
tory tract for
which antibi-
otics were pre-
Index consul-
tation
Review groups
= 6
Review groups
= 6
-10.7 (-20.3 to
-1.0)j
- Practice =
0.17
Review group =
0.09
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Table 2. Antibiotic prescriptions per index consultation or population rate over time (Continued)
scribed
aTwo level (practice and patient) random intercept logistic regression models.
bAfter backward elimination, four explanatory variables remained in the model: patients’ disease severity, measured on a four-point
scale (odds ratio 4.8, 95% CI 3.9 to 5.9 per step on scale, P value < 0.001), and average practice severity (severity of the disease rated
by the GP) (odds ratio 0.14, 95% CI 0.06 to 0.33, P value < 0.001 per category step on the scale), patients having fever (odds ratio
1.80, 95% CI 1.35 to 2.39, P value < 0.001 compared with no fever) and frequency of fever in practice, as determined by the log odds
(odds ratio 1.31, 95% CI 1.08 to 1.59, P value = 0.007 per category step on the scale).
cLogistic regression with random effects for each cluster and patient covariates (age, sex, education, days with restrictions at baseline).
dThe adjusted model adjusted for baseline prescribing and clustering by physician and practice, and additionally controlled for age,
smoking, sex, major cardiovascular or respiratory comorbidity, baseline symptoms, crepitations, wheeze, pulse higher than 100 beats
per minute, temperature higher than 37.8°C, respiratory rate, blood pressure, physician’s rating of severity and duration of cough.
eAdjusted for cluster design, baseline values and patient age group (for analyses at teaching unit and physician levels).
f P value adjusted for baseline values and the study’s cluster design.
gCalculated and inflated for clustering by using standard deviation inflated by variance inflation factor.
hCalculated from secondorder penalised quasi-likelihoodmultilevel logistic regressionmodel adjusted for variance at general practitioner
and practice level (random intercept at practice and general practitioner level). Models included both interventions and interaction
term of interventions.
iP values from multilevel linear regression model to account and correct for variation at the level of family physician, and to adjust for
both interventions, RTI-episodes treated with antibiotics during baseline period, chronic obstructive pulmonary disease comorbidity.
j Intervention effect in multi-level analysis
CI: confidence interval
GP: general practitioner
NR: not reported
Table 3. Number or rate of re-consultations
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Briel (2006) Re-
consultations
Within 14
days
n/N (%)
113/253 (44.
7)
n/N (%)
143/290 (49.
3)
Ad-
justed rate ra-
tio (95% CI)a
0.97 (0.78 to
1.21)
NR -
Butler (2013) Re-consulta-
tions after in-
dex consulta-
tion)b
Within 7 days
Within 14
days
Within 31
days
Median (IQR)
2.66 (1.88 to
4.25)
5.10 (4.70 to
7.92)
9.06 (7.53 to
12.62)
Median (IQR)
3.35 (2.16 to
4.31)
6.43 (4.04 to
7.84)
11.38 (7.39 to
14.05)
Median differ-
ence (95%CI)
c
-0.65 (-1.69 to
0.55)
-1.33 (-2.12 to
0.74)
-2.32 (-4.76 to
1.95)
P value = 0.
446d
P value = 0.
411d
P value = 0.
503d
-
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Table 3. Number or rate of re-consultations (Continued)
Cals (2009) Re-
consultations
Within 28
days
n/N = 56/201
% crude (95%
CI)e
27.9 (21.4 to
34.4)
n/N = 85/230
% crude (95%
CI)e
37.0 (30.4,
43.6)
Absolute dif-
ference
9.1 (% crude)
0.14f ICC = 0.01
Francis
(2009)
Re-
consultationg
Within 14
days
n/N (%)
33/256 (12.9)
n/N (%)
44/272 (16.2)
Adjusted odds
ratio (95%
CI)
0.75 (0.41 to
1.38)
NR ICC = 0.06
Légaré
(2012)
Re-
consultation
Baseline (pre) 21.6 (12.1 to
29.7)
22.7 (10.3 to
27.3)
Ad-
justed risk ra-
tio (95% CI)h
1.3 (0.7 to 2.
3)
Absolute dif-
ference = 7.5
NR -
Within 14
days (post)
13.4 (9.9 to
15.9)
15.2 (11.9 to
19.4)
Little (2013) New or wors-
ening
symptomsi
- n/N (%)
451/2242
(20%)
n/N (%)
309/1879
(16%)
Ad-
justed risk ra-
tio (95% CI)j
1.33 (0.99 to
1.74)
P value = 0.
055
-
aPoisson regression with random effects for each cluster and patient covariates (age, sex, education, days with restrictions at baseline).
bCollected from the electronic records of a subsample of 37 general practices (20 intervention/17 control). 47 patients (10.9%) re-
consulted more than once within 28 days with pattern similar across groups.
cComputed with bootstrapping methods.
dFrom Mann-Whitney U test.
eCalculated and inflated for clustering by using standard deviation inflated by variance inflation factor.
fCalculated from secondorder penalised quasi-likelihoodmultilevel logistic regressionmodel adjusted for variance at general practitioner
and practice level (random intercept at practice and general practitioner level). Models included both interventions and interaction
term of interventions.
gParental report that child attended a face-to-face consultation with a primary care clinician in their general practice, or with an out of
hours provider, in the 2 weeks after registration.
hAdjusted for cluster design and baseline values.
iDefined as re-consultation for new or worsening symptoms within 4 weeks, new signs or hospital admission.
jThe adjusted model adjusted for baseline prescribing and clustering by physician and practice, and additionally controlled for age,
smoking, sex, major cardiovascular or respiratory comorbidity, baseline symptoms, crepitations, wheeze, pulse higher than 100 beats
per minute, temperature higher than 37.8°C, respiratory rate, blood pressure, physician’s rating of severity and duration of cough.
CI: confidence interval
ICC: intra-class correlation co-efficient
IQR: interquartile range
NR: not reported
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Table 4. Incidence of hospital admissions
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Briel (2006) Hospital
admissions
< 28 days
of study enrol-
ment
n/N = 2/253 n/N = 1/290 NR NR -
Butler (2012) Hospital
admissionsa
Baseline
Follow-up
Mean
7.7
7.5
Mean
8.7
8.0
% reduc-
tion (interven-
tion relative to
controlsb
(95% CI)
-1.9 (-13.2 to
8.2)
P value = 0.72 -
Cals (2013) Hospital
admissions
Mean 3.67
year follow-up
n/N
0/178
n/N
5/201
NR NR -
Francis
(2009)
Hospital
admissions (or
observed in a
paediatric as-
sessment unit)
< 14 days n/N
3/256
n/N
4/272
NR NR -
Little (2013) Hospital
admissionsc
< 4 weeks n/N
6/1170
n/N
2/870
NR - -
aAnnual number of hospital episodes for possible respiratory tract infections and complications of common infections per 1000
registered patients. A single admission occurred if patient admitted to hospital for a possible RTI or complication. If patient admitted
more than once, and gap between admissions was 30 days or more, this was considered a separate complication episode.
bDifference between means in intervention group and control group as percentage of mean control group.
cFactorial analysis data not reported
NR: not reported
RTI: respiratory tract infection
SAEs: serious adverse events
Table 5. Incidence of pneumonia
Author Outcome Measurement
time point
Intervention Control Effect estimate P value Notes
Briel (2006) Pneumonia < 28 days n/N = 0/253 1/290 NR NR -
Cals (2013) Pneumonia Mean 3.67
year follow-up
n/N = 0/178 n/N = 1/201 NR NR -
NR: not reported
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Table 6. Patient satisfaction
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Briel (2006) Patient satis-
faction
(Patient Satis-
faction Ques-
tionnaire)a
7 and 14 days 121/253 (47.
8)
142/290 (49.
0)
Adjusted OR
(95% CI)b
1.00 (0.64 to
1.31)
NR -
Cals (2009) Patient satis-
faction (% at
least ’very sat-
isfied’ on Lik-
ert scale)c
28 days n/N = 144/
201
% (crude 95%
CI)d
78.7 (72.5 to
84.9)
n/N = 151/
230
% (crude 95%
CI)d
74.4 (68.2 to
80.6)
4.3 P value = 0.88
e
-
Francis
(2009)
Parent satis-
faction (Likert
scale)f
14 days n/
N (%) = 222/
246 (90.2)
n/
N (%) = 246/
263 (93.5)
Adjusted OR
(95% CI)g
0.6 (0.3 to 1.
2)
NR -
Welschen
(2006)
Patient satis-
faction (Likert
scale)h
Index consul-
tation
Patient satis-
faction (%)
Baseline (pre)
= 4.3 (0.3)
Follow-
up (post) = 4.
3 (0.3)
% change
(SD) = 0 (0.4)
Patient satis-
faction (%)
Baseline (pre)
= 4.2 (0.4)
Follow-
up (post) = 4.
2 (0.3)
% change
(SD): 0 (0.4)
Mean
difference of
changes (95%
CI)
0 (-0.2 to 0.1)
i
NR -
a% patients with a maximum score of 70 reported, as satisfaction scores (scale 14 to 70; median 68/70) were highly skewed.
bLogistic regression with random effects for each cluster and patient covariates (age, sex, education, days with restrictions at baseline).
c% at least ’very satisfied’.
dCalculated and inflated for clustering by using standard deviation inflated by variance inflation factor.
eCalculated from models adjusted for variance at general practitioner and practice level.
fTransformed into binary outcomes: ’very satisfied’ and ’satisfied’ versus ’neutral’, ’dissatisfied’ and ’very dissatisfied’.
gOdds ratio (95% CI) from multilevel modelling.
h1 = very dissatisfied to 5 = very satisfied.
iIntervention effect in multilevel analysis.
CI: confidence interval
OR: odds ratio
SD: standard deviation
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Table 7. Decisional conflict
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Légaré
(2012)
Deci-
sional conflict
(GPs)a
Immediately
after consulta-
tion
Baseline: 4.5
(0 to 9.0)
Follow-up: 4.
6 (0 to 6.1)
Baseline: 3.0
(0 to 5.9)
Follow-up:1.1
(0 to 2.4)
Adjusted RR
3.4 (0.3 to 38.
0)
NR -
Légaré
(2012)
Deci-
sional conflict
(patients)a
Immediately
after consulta-
tion
Baseline: 5.1
(0 to 13.5)
Follow-up: 4.
6 (2.6 to 7.4)
Baseline: 4.2
(0 to 8.9)
Follow-up: 6.
3 (0 to 12.8)
Adjusted RR:
0.8 (0.2 to 2.
4)
NR -
Légaré
(2011)
Correlation of
deci-
sional conflict
between GPs
and patientsa
Immediately
after consulta-
tion
Baseline: 0.14
Follow-up: 0.
24
Baseline: -0.
05
Follow-up: 0.
02
Differ-
ence at follow-
up (95% CI)
0.26 (-0.06 to
0.53)
0.06 -
aProportion of participants who had a value of 2.5 or more on the Decision Conflict Scale (where 1 = low decisional conflict and 5 =
very high decisional conflict).
bPresented as correlation of family physicians’ and patient’s DCS scores (Pearson’s r).
CI: confidence interval
GP: general practitioner
NR: not reported
RR: risk ratio
Table 8. Decisional regret
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Légaré
(2012)
Decisional re-
gret a
2 weeks after
consultation
Baseline: 10.5
± 15.4
Follow-up:
12.4 ± 19.1
Baseline: 10.8
± 20.8
Follow-up: 7.
6 ± 13.7
Adjusted
mean
difference
4.8 (0.9 to 8.
7)
- -
Légaré
(2011)
Patients
(%) with deci-
sional regret
2 weeks after
consultation
Baseline: 1
Follow-up: 7
Baseline: 1
Follow-up: 9
Differ-
ence at follow-
up (95% CI)
-2 (-12 to 5)
0.91 -
a = Decisional Regret Scale used, where 0 = very low regret and 100 = very high regret
CI: confidence interval
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Table 9. Patient enablement
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Briel (2006) Patient en-
ablement (Pa-
tient Enable-
ment Instru-
ment; scale 0
to 12)
7 and 14 days Mean (SD): 8.
49 (1.98)
Mean (SD): 8.
15 (2.03)
Adjusted co-
efficient (95%
CI)a
0.35 (-0.05 to
0.75)
NR -
Cals (2009) Patient en-
ablement (Pa-
tient Enable-
ment In-
strument; max
score is 12)
28 days Median (IQR)
score: 3 (4)
Mean (SD)
score: 3.29 (2.
52)
Median (IQR)
score: 3 (4)d
Mean (SD)
score: 3.06 (2.
54)
- NR
0.70b
-
Francis
(2009)
Parent enable-
ment
(Modified Pa-
tient Enable-
ment Instru-
ment, scale 1
to 10)c
14 days n/N (%): 99/
246 (40.2)
n/N (%): 94/
262 (35.9)
Adjusted OR
(95% CI)
1.20 (0.84 to
1.73)
NR -
aLinear regression with random effects for each cluster and patient covariates (age, sex, education, days with restrictions at baseline).
bCalculated from models adjusted for variance at general practitioner and practice level.
cPresented results are % with parent enablement score of 5 or more (binary outcome).
dComparator is ’no skills training’.
CI: confidence interval
IQR: interquartile range
NR: not reported
OR: odds ratio
SD: standard deviation
Table 10. Quality of the decision made (GPs)
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Légaré
(2012)
Quality of
decision made
(GPs) (0 to 10
Likert scale)
After consul-
tation
Baseline: 8.7 ±
1.5
Follow-up: 8.
5 ± 1.6
Baseline: 8.7 ±
1.5
Follow-up: 8.
5 ± 1.5
Adjusted
mean
difference
0.0 (-0.4 to 0.
4)
NR -
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Table 10. Quality of the decision made (GPs) (Continued)
Légaré
(2011)
Quality of
decision made
(GPs) (0 to 10
Likert scale)
After consul-
tation
Baseline: 8.8 ±
1.1
Follow-up: 8.
7 ± 1.2
Baseline: 8.3 ±
1.4
Follow-up: 8.
5 ± 1.3
Differ-
ence at follow-
up (95% CI)
0.2 (-0.34 to
0.89)
0.29 -
CI: confidence interval
GP: general practitioner
NR: not reported
Table 11. Quality of the decision made (patients)
Author Outcome Measurement
time point
Intervention Control Effect
estimate
P value Notes
Légaré
(2012)
Quality of de-
ci-
sionmade (pa-
tients) (0 to 10
Likert scale) a
After consul-
tation
Baseline: 8.2 ±
1.1
Follow-up: 8.
2 ± 1.3
Baseline: 8.2 ±
1.4
Follow-up: 8.
4 ± 1.0
Adjusted
mean
difference
0.2 (-0.6 to 0.
2)
NR -
Légaré
(2011)
Quality of the
decision made
(patients)
(0 to 10 Likert
scale) a
After consul-
tation
Baseline: 8.2 ±
2.1
Follow-up: 8.
7 ± 1.9
Baseline: 8.4 ±
1.9
Follow-up: 8.
6 ± 1.9
Differ-
ence at follow-
up (95% CI)
0.1 (-0.88 to
0.94)
0.57 -
aLikert scale where 0 = very low quality and 10 = very high quality.
CI: confidence interval
NR: not reported
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
1 exp Respiratory Tract Infections/ (297579)
2 (respiratory adj2 (infection* or inflam*)).tw. (31350)
3 pharyngitis.tw. (4164)
4 sinusit*.tw. (11403)
5 (acute adj2 rhinit*).tw. (174)
6 (rhinosinusit* or nasosinusit*).tw. (4197)
7 common cold*.tw. (2806)
8 coryza.tw. (379)
9 (throat* adj2 (sore* or inflam* or infect*)).tw. (3897)
10 laryngit*.tw. (1305)
11 tonsillit*.tw. (4080)
12 bronchit*.tw. (18478)
13 bronchiolit*.tw. (8053)
14 pneumon*.tw. (133425)
15 (bronchopneumon* or pleuropneumon*).tw. (5382)
16 Cough/ (12409)
17 cough*.tw. (34227)
18 exp Otitis Media/ (21649)
19 otitis media.tw. (16032)
20 (aom or ome).tw. (6083)
21 Croup/ (970)
22 (croup or pseudocroup or laryngotracheobronchit* or laryngotracheit*).tw. (1971)
23 or/1-22 (451019)
24 exp Anti-Bacterial Agents/ (537825)
25 antibiotic*.tw,nm. (242634)
26 or/24-25 (640170)
27 23 and 26 (79549)
28 exp Decision Making/ (122846)
29 exp decision support techniques/ (62827)
30 exp Decision Theory/ (9884)
31 (decision* or decid* or option* or choice* or choose* or deliberat*).tw. (618268)
32 exp Informed Consent/ (35917)
33 (informed adj3 (consent* or agree* or assent*)).tw. (23002)
34 Health Knowledge, Attitudes, Practice/ (74387)
35 “Attitude of Health Personnel”/ (92103)
36 professional-patient relations/ or physician-patient relations/ (82522)
37 exp Consumer Participation/ (32440)
38 ((patient* or consumer* or carer* or parent* or child* or individual* or person* or interpersonal*) adj5 (participat* or involv* or
collabor* or cooperat* or co-operat* or engag* or consult* or feedback* or interaction*)).tw. (184609)
39 (values* or prefer*).tw. (981018)
40 exp Communication/ (369188)
41 (communicat* or negotiat* or facilitat* or discuss*).tw. (1366627)
42 health education/ or exp consumer health information/ or patient education as topic/ (125443)
43 ((patient* or consumer* or parent*) adj3 (educat* or informat*)).tw. (58615)
44 (shar* adj2 information*).tw. (3292)
45 sdm.tw. (869)
46 ((patient* or client* or subject or person or consumer* or family or families or carer* or care giver*) and (professional* or physician*
or clinician* or practitioner*)).tw. (327702)
47 Risk Assessment/ (180413)
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48 ((check or clarify) adj3 understanding).tw. (222)
49 (patient adj2 (understanding or expect*)).tw. (3479)
50 problem defin*.tw. (230)
51 (ask adj2 question*).tw. (1819)
52 (assess* adj2 risk*).tw. (50234)
53 self-manag*.tw. (8193)
54 equipoise.tw. (596)
55 checklist*.tw. (18085)
56 (goal adj2 set*).tw. (2180)
57 consensus.tw. (98026)
58 concordance.tw. (26142)
59 agreement*.tw. (155845)
60 (action* adj2 plan*).tw. (5452)
61 or/28-60 (3975067)
62 27 and 61 (14717)
Appendix 2. EMBASE (Elsevier) search strategy
#53 #23 AND #26 AND #52 28861
#52 #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41
OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 3678076
#51 ’self-manage’:ab,ti OR equipoise:ab,ti OR checklist:ab,ti OR consensus:ab,ti OR concordance:ab,ti OR agreement*:ab,ti OR
(action* NEAR/2 plan*):ab,ti OR (goal NEAR/2 set*):ab,ti AND [embase]/lim298331
#50 (assess* NEAR/2 risk*):ab,ti AND [embase]/lim53641
#49 (ask NEAR/2 question*):ab,ti AND [embase]/lim1736
#48 (problem NEAR/1 defin*):ab,ti AND [embase]/lim327
#47 (patient NEAR/2 (understanding OR expect*)):ab,ti AND [embase]/lim4348
#46 ((check OR clarify) NEAR/3 understanding):ab,ti AND [embase]/lim203
#45 ’risk assessment’/de AND [embase]/lim276013
#44 patient*:ab,ti OR client*:ab,ti OR subject:ab,ti OR person:ab,ti OR consumer*:ab,ti OR family:ab,ti OR families:ab,ti OR carer*:
ab,ti OR ’care giver’:ab,ti OR ’care givers’:ab,ti AND (professional*:ab,ti OR physician*:ab,ti OR clinician*:ab,ti OR practitioner*:
ab,ti) AND [embase]/lim349162
#43 sdm:ab,ti AND [embase]/lim776
#42 (shar* NEAR/2 information*):ab,ti AND [embase]/lim2631
#41 ((patient* OR consumer* OR parent*) NEAR/3 (educat* OR informat*)):ab,ti AND [embase]/lim59024
#40 ’patient education’/de OR ’consumer health information’/de AND [embase]/lim41224
#39 communicat*:ab,ti OR negotiat*:ab,ti OR facilitat*:ab,ti OR discuss*:ab,ti AND [embase]/lim1335786
#38 ’interpersonal communication’/de OR ’communication skill’/de OR ’nonverbal communication’/exp OR ’persuasive communi-
cation’/de OR ’verbal communication’/de OR ’conversation’/de AND [embase]/lim117435
#37 values*:ab,ti OR prefer*:ab,ti AND [embase]/lim995711
#36 ((patient* OR consumer* OR carer* OR parent* OR child* OR individual* OR person* OR interpersonal*) NEAR/5 (participat*
OR involv* OR deliberat* OR collabor* OR cooperat* OR ’co-operate’ OR ’co-operates’ OR
’co-operation’ OR engag* OR consult* OR feedback* OR interaction*)):ab,ti AND [embase]/lim197067
#35 ’patient participation’/de AND [embase]/lim6904
#34 ’doctor patient relation’/de AND [embase]/lim39102
#33 ’attitude to health’/de AND [embase]/lim7634
#32 (treatment* NEAR/2 option*):ab,ti AND [embase]/lim65145
#31 (informed NEAR/3 (consent* OR agree*)):ab,ti AND [embase]/lim32077
#30 ’informed consent’/de AND [embase]/lim39300
#29 decision*:ab,tiORdecid*:ab,tiORoption*:ab,tiOR choice*:ab,tiOR choose*:ab,tiORdeliberat*:ab,ti AND [embase]/lim639112
#28 ’decision support system’/de AND [embase]/lim4763
#27 ’decision making’/de OR ’patient decision making’/de OR ’medical decision making’/de OR ’clinical decision making’/de AND
[embase]/lim158809
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#26 #24 OR #25 892667
#25 antibiotic*:ab,ti AND [embase]/lim219681
#24 ’antibiotic agent’/exp AND [embase]/lim842466
#23 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 518323
#22 croup:ab,ti OR pseudocroup:ab,ti OR laryngotracheobronchit*:ab,ti OR laryngotracheit*:ab,ti AND [embase]/lim1492
#21 ’otitis media’:ab,ti OR aom:ab,ti OR ome:ab,ti AND [embase]/lim19731
#20 ’otitis media’/exp AND [embase]/lim21150
#19 cough*:ab,ti AND [embase]/lim37668
#18 ’coughing’/de AND [embase]/lim52337
#17 bronchopneumon*:ab,ti OR pleuropneumon*:ab,ti AND [embase]/lim3817
#16 pneumon*:ab,ti AND [embase]/lim131768
#15 bronchiolit*:ab,ti AND [embase]/lim8788
#14 bronchit*:ab,ti AND [embase]/lim15885
#13 tonsillit*:ab,ti AND [embase]/lim3497
#12 laryngit*:ab,ti AND [embase]/lim1237
#11 (throat* NEAR/2 (sore* OR inflam* OR infect*)):ab,ti AND [embase]/lim4582
#10 ’sore throat’/de AND [embase]/lim8854
#9 ’common cold’:ab,ti OR ’common colds’:ab,ti OR coryza:ab,ti AND [embase]/lim2828
#8 ’common cold symptom’/de AND [embase]/lim269
#7 rhinosinusit*:ab,ti OR nasosinusit*:ab,ti AND [embase]/lim4585
#6 (acute NEAR/2 rhinit*):ab,ti AND [embase]/lim179
#5 sinusit*:ab,ti AND [embase]/lim11343
#4 pharyngit*:ab,ti AND [embase]/lim4248
#3 (respiratory NEAR/2 (infection* OR inflam*)):ab,ti AND [embase]/lim33268
#2 ’respiratory tract inflammation’/exp AND [embase]/lim275986
#1 ’respiratory tract infection’/exp AND [embase]/lim198937
Appendix 3. Web of Science (Thomson Reuters) search strategy
#7 #6 AND #5
DocType = All document types; Language = All languages;
#6 TOPIC: (random* or placebo* or ((singl* or doubl*) NEAR/1 blind*) or allocat* or crossover* or “cross over”) OR TITLE: (trial)
DocType=All document types; Language=All languages;
#5 #4 AND #3
DocType=All document types; Language=All languages;
#4 TOPIC: (sdm or decision* or decid* or choice* or prefer* or option*) OR TOPIC: ((informed NEAR/3 (consent* or agree*))) OR
TOPIC: ((patient* or consumer* or parent* or personal* or individual* or interpersonal*) NEAR/2 (participat* or involv*))
DocType=All document types; Language=All languages;
#3 #2 AND #1
DocType=All document types; Language=All languages;
#2 TOPIC: (antibiotic* or antibacterial* or anti-bacterial*)
DocType=All document types; Language=All languages;
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(Continued)
#1 TOPIC: (pharyngit* or sinusit* or “acute rhinitis” or rhinosinusit* or nasosinusit* or “common cold*” or coryza or laryngit* or tonsillit*
or bronchit* or bronchiolit* or pneumon* or bronchopneumon* or pleuropneumon* or cough* or “otitis media” or aom or ome or croup
or pseudocroup or laryngotracheit* or laryngotracheobronchit*) OR TOPIC: ((respiratory NEAR/2 (infect* or inflam*)) or (throat*
NEAR/2 (sore* or inflam* or infect*)))
DocType=All document types; Language=All languages;
WH A T ’ S N E W
Date Event Description
8 February 2017 Amended Minor formatting change to Table 1 with rows and columns swapped, to improve ease of reading
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S O U R C E S O F S U P P O R T
Internal sources
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Decision Making; Acute Disease; Anti-Bacterial Agents [∗therapeutic use]; Patient Participation; Primary Health Care; Randomized
Controlled Trials as Topic; Respiratory Tract Infections [∗drug therapy]
MeSH check words
Humans
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